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Abstract
Feline Spongiform Encephalopathy (FSE) was first reported in 1990 by Wyatt et a l,  
over three years after Bovine Spongiform Encephalopathy (BSE) was first identified. 
At present only limited published clinical and pathological descriptions o f FSE are 
available. The aims of this thesis are therefore to review the current literature on FSE 
and describe the clinical and pathological features o f the cases in this study.
The nine naturally occurring cases of FSE included in this thesis were presented to 
Glasgow University Veterinary School during the period of June 1990 to April 1998. 
A set o f clinical criteria was identified allowing a presumptive ante-mortal diagnosis 
o f FSE. These included: progressive behavioural changes, hyperaesthesia, ataxia, 
hypersalivation and intermittent pupillary dilatation, although not all where present in 
every case. No evidence of a breed or sex predilection, geographic clustering, reliable 
routine diagnostic test or successful treatment modality could be identified.
The nature and distribution of the pathological changes are very similar in all cases in 
this series, with the significant changes confined to the central nervous system (CNS). 
The changes include vacuolation of grey matter neuropil, vacuolation of individual 
neurones, Wallerian-type degeneration and a reactive astrocytosis. Neuropil 
vacuolation is widespread, but certain regions (including the cerebellar granule cell 
layer, deep cerebral layers, thalamus, basal nuclei and septal nuclei) appear to be 
preferentially affected. Vacuolation of individual neurones is selectively present in 
the dorsal nucleus of the vagal nerve and raphe nuclei, and occasionally present in the 
hypoglossal nucleus, vestibular nuclei and reticular formation. Characteristic patterns 
of pathological PrP accumulation in the CNS are evident on PrP 
immunocytochemistry, using monoclonal antibody 3F4 raised against hamster PrP. 
Aspects of the spongiform changes and PrP immunocytochemistry in these cases bear 
strong similarities to new variant CJD (vCJD), although with some differences. These 
similarities are consistent with circumstantial evidence suggesting that both FSE and 
vCJD originated from ingestion of material contaminated with the infective agent 
responsible for BSE (Bruce et al. 1997; Collinge et al. 1996).
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Introduction: review o f feline spongiform encephalopathy
1.1 Review of Feline Spongiform Encephalopathy
1.1.1 History
The first case of feline spongiform encephalopathy (FSE) was that reported by Wyatt 
et al. (1990), over three years after BSE was identified. The cat, a five year old male 
neutered Siamese with a history o f progressive ataxia and neurological signs, was 
presented to the University o f Bristol Veterinary School. Attempted treatment did not 
result in any improvement and the cat was subsequently euthanased and a diagnosis of 
a spongiform encephalopathy was made, based on the histopathological appearance. 
A retrospective review o f reports and tissue sections from cats presented with 
neurological disease was performed both at the University o f Bristol Veterinary 
School and the University o f Liverpool Veterinary School (Pearson et al. 1993). 
Cases going back to 1975 were reviewed and revealed no evidence o f a similar 
disease. The only cases that had evidence o f spongiform changes were two kittens 
with congenital spongiform changes o f the white matter (Kelly and Gaskell 1976). 
FSE was, therefore, judged to be a novel disease.
Experimental infection o f cats with FSE has been achieved, with the first successful 
transmission occurring as early as 1972 when a 34% transmission rate was reported 
on inoculation o f cats with human brain suspension from patients with Creutzfeldt- 
Jakob Disease (CJD) (Amyx et al. 1983). In addition cats have been used as 
experimental models to study transmissible spongiform encephalopathies (TSE’s) 
(Amyx et al. 1983; Gourmelon et al. 1987; Mitrova and Mayer 1977). The clinical 
signs of experimental and naturally occurring FSE are similar, although sleep pattern 
abnormalities were reported more frequently in the experimental cases in which only 
discrete to minimal spongiosis was detected microscopically.
Subsequent to its demonstration in domestic cats, FSE has also been reported in a 
number o f captive exotic felidae (Willoughby et al. 1992; Kirkwood and Cunningham 
1994a,b), all o f which can be traced back to the UK.
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1.1.2 Occurrence
1.1.2.1 Domestic Cats
FSE has been reported from all regions of the UK, including Northern Ireland and 
some of the smaller offshore islands. To the 1st of January 1998, 81 cases of FSE had 
been reported in the UK. In addition to the cases reported in the UK, single cases 
have been reported in Norway (Bratberg et al. 1995), Italy (Zanusso et al 1998), 
Liechtenstein and the Republic of Ireland. The case in Norway had been fed a variety 
of commercial, dry cat foods imported from the UK, but no other contact with the UK 
was evident, either directly or genetically.
Clinical details for the first 24 cases reported in the UK are available (Pearson et a l 
1993), which includes one o f the cases from Glasgow Veterinary School (Leggett et 
al. 1990). Additionally the clinical details of the FSE cases from Norway and Italy 
have been published (Bratberg et al. 1995; Zanusso et al 1998). The age and sex 
distribution of the 26 reported cases of FSE in domestic cats are shown in Table 1. 
Based on the initial sex distribution of the 24 reported UK cases, a male predilection 
was suspected but the number of cats in the series was considered too small for 
significant conclusions to be made (Pearson et al. 1993).
The reported University of Bristol Veterinary School cases originated from a wide 
geographic distribution including Yorkshire, the Midlands, South Wales, the South 
West and Guernsey. More extensive clinical details for these 11 cases (Pearson et al.
1993) and for a number of the individual case reports (Bratberg et al. 1995; Leggett et 
al. 1990; Synge and Waters 1991; Zanusso et al 1998) are summarised in Table 2.
1.1.2.2 Captive Wild Felidae
Up to the 1st of January 1998, FSE has been reported in seven cheetahs (which 
includes one each in Australia, the Republic of Ireland and France) (Kirkwood and 
Cunningham 1994a,b; Peet and Curran 1992), three pumas (Willoughby et al. 1992), 
one tiger and two ocelots.
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Table 1 Age and sex of the 26 published cases of FSE in domestic cats.
Bristol: 1 Siamese 6 MN
2 Domestic shorthair 8 MN
3 Domestic shorthair 8 MN
4 Domestic shorthair 5 MN
5 Domestic shorthair 4 MN
6 Domestic longhair 5 MN
7 Domestic shorthair 10 FN
8 Domestic shorthair 8 MN
9 Domestic shorthair 2 MN
10 Persian 4 F
11 Domestic shorthair 9 MN
Glasgow Domestic shorthair 7 FN
Shetland Not stated 4 MN
Italy Domestic shorthair 7 FN
Norway Domestic shorthair 6 FN
Table 2 Available clinical details of published FSE cases in domestic cats.
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A second tiger tested positive for FSE, but was not showing relevant clinical signs at 
the time of death. One of the Ocelots was presented to Glasgow Veterinary School. 
The three cheetahs, which developed FSE outside the UK, had all originally been 
exported from the UK where it is likely that they were exposed to the disease.
1.1.3 Clinical Presentation
1.1.3.1 Domestic Cats
In all except one o f the reported cases (Bratberg et al. 1995; Gruffydd-Jones et a l 
1991; Leggett et al. 1990, Pearson et al. 1993, Synge and Waters 1991) the clinical 
signs were characterised as being insidious in onset and slowly progressive. In the 
majority of cases, altered behaviour was the first clinical sign although some owners 
reported ataxia as the initial abnormality. The altered behaviour included timidity, 
manifested as fear o f human contact or fear o f going outside or aggression directed at 
the owners or other household pets. In addition to the altered behaviour, all the cases 
developed hind-limb ataxia, which progressed to involve the forelimbs in advanced 
cases. The ataxia was characterised by a rapid, crouching, hypermetric gait and an 
inability to judge distances. In some cases, a fine continuous tremor especially of the 
head and ears was noted.
Further signs observed in a variable number of cases included the presence of 
hyperaesthesia, either to auditory or tactile stimuli, dilated but responsive pupils, 
altered grooming, polyphagia and polydipsia, persistent or intermittent 
hypersalivation and head pressing.
In the case from Italy (Zanusso et al 1998) the reported clinical features differed 
slightly, with the onset being more rapid and initially characterised by the presence of 
frenzy, twitching of the body and hyperaesthesia. This was followed by the 
development o f ataxia.
The clinical sings observed in the first 11 cases presented to the University of Bristol 
Veterinary School are summarised in Table 3.
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Ataxia 
Altered behaviour
• aggression
• timidity 
Tactile
hyperaesthesia _____________________________________________________
Auditory
hyperaesthesia __________ _____________________________________
Polyphagia
Altered grooming
• decreased
• increased 
Hypermetria
Hypersalivation 
Polydipsia 
Crouching gait
Pupillary dilation
Poor judge of
distances _______________________
Jaw chattering 
Head nodding 
Head pressing
-  i -------------1------------- 1------------- 1-------------1-------------1-------------1-------------1------------- 1------------- 1------------- i
0 1  2 3 4 5 6 7 8 9  10 11
Table 3 Clinical signs observed in 11 cases of FSE (Pearson et al. 1993)
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1.1.3.2 Captive Wild Felidae
FSE in captive wild felidae is characterised by the development o f ataxia and 
progression o f the clinical signs over a three-week to eight-week period (Bradley 
1997). In addition to ataxia, the cheetahs exhibited variable signs including 
hyperaesthesia, weight loss, falling and muscle spasms (Kirkwood and Cunningham
1994), while the puma showed apprehension, difficulty balancing and a fine, whole- 
body tremor (Willoughby et a l  1992).
1.1.4 Pathology
No laboratory methods are currently available for the antemortem diagnosis of the 
TSE’s and therefore the principle method o f diagnosis relies upon the histological 
examination o f the brain.
Histopathological changes in the TSE’s are confined to the central nervous system 
and include vacuolation o f the neuronal perikarya and neurites, neuronal degeneration 
and loss, gliosis (principally an astrocytosis) and amyloidosis (Wells and McGill 
1992). Primary degenerative changes of the white matter, unrelated to the neuronal 
degeneration and loss, have not been recognised in the naturally occurring TSE’s of 
animal species but have been described experimentally in mice. The vacuolation of 
the neurites gives the appearance of a spongiform change within the grey matter 
neuropil. The vacuolation o f the neuronal perikarya and spongiform changes 
characteristically have a bilaterally symmetrical distribution and the pattern o f these 
changes appears to be strongly conserved where the same prion strain and the same 
species are involved. The appearance and distribution of the neuronal perikaryon 
vacuolation and the spongiform changes can be regarded as pathognomonic (Wells 
and McGill 1992).
The neuronal loss in the animal TSE’s may not be obvious in every case and the 
vacuolated perikarya may appear otherwise normal. The astrocytosis has been 
regarded as either a purely secondary phenomenon or one that is closely associated 
with agent replication. Amyloidosis has been described in all TSE’s occurring in 
animal, apart from transmissible mink encephalopathy and feline spongiform 
encephalopathy, although in other species it is not a constant feature.
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1.1.4.1 Domestic Cats
In none o f the reported cases of FSE were any significant gross abnormalities visible 
at autopsy. The reported histological findings in all the domestic cats with FSE are 
similar and characterised primarily by vacuolation of the grey matter. The authors of 
the case report from Italy (Zanusso et al 1998) suggested that the neuropathological 
changes in their case was at variance with other reported cases of FSE, but did not 
publish a detailed neuropathological description.
In comparison to other TSE’s in animals, with particular reference to Bovine 
Spongiform Encephalopathy (BSE), FSE has been reported to have severe vacuolar 
changes accompanied by an intense astrocytic and microglial reaction (Wells and 
McGill 1992). The vacuolar changes in FSE appear to have a pattern o f distribution 
different from that o f BSE with the cerebral cortex, corpus striatum, thalamus and 
medial geniculate body more prominently and consistently involved (Wyatt et a l
1991).
In the review o f the first 24 cases of FSE in the UK, Wyatt et a l  (1991) report that the 
vacuolar changes o f the grey matter consisted o f two types: spongiform change and 
vacuolation o f the perikarya o f neurons.
The predominant type of grey matter vacuolar change was spongiform change, which 
was evident as small, discrete spaces with no visible content in the grey matter 
neuropil. The spongiform changes were present through the central nervous system, 
but were consistently more evident in certain areas which included the medial 
geniculate body, the corpus striatum and the thalamus. In addition to these areas, in 
most cases the cerebellum and the deeper layers o f the cerebral hemispheres were 
moderately severely affected.
Vacuolation of neuronal perikarya was evident as large, single or multiple vacuoles 
with a clearly defined margin. The predilection areas for this type of change were the 
raphe nucleus, the dorsal nucleus o f the vagus nerve, the vestibular nuclei and the red 
nucleus. Occasional vacuolation of the neuronal soma was reported in the spinal cord 
with other neuronal changes being infrequent.
In all cases, a glial reaction (predominantly of astrocytes, but also microglia) was 
present. In some instances vacuolation and axonal degeneration was present in the 
white matter, particularly in the pyramidal tracts.
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Fresh brain tissue from five cases of FSE was examined for the presence of scrapie- 
associated fibrils and PrPSc (protease-resistant disease related isoform of prion 
protein) (Pearson et a l 1992), which can be considered as molecular markers 
confirming the presence o f a TSE. The PrPSc is extracted from the brain tissue by 
detergent followed by protease treatment, resulting in a protease-resistant core in 
which scrapie-associated fibrils can be demonstrated by negative stain electron 
microscopy. In all five cases of FSE, the brain tissue was positive for the presence of 
scrapie-associated fibrils and PrPSc. In addition, one other cat with neurological signs, 
but no histological evidence of spongiform changes, was positive for scrapie- 
associated fibrils and PrPSc. It was suggested that this was a pre-clinical case of FSE. 
Scrapie-associated fibrils in the absence o f PrPSc were demonstrated in two other cats, 
one with neurological signs and a histologically confirmed meningioma and a second 
with no neurological signs or histopathological brain abnormalities.
In the single case report from Italy the authors support their claim of a new variant of 
FSE on the basis o f the differing clinical presentation, the uncharacteristic 
neuropathology and the presence of type-1 PrPSc, rather than the expected BSE- 
associated type-4 PrPSc.
1.1.4.2 Captive Wild Felidae
Pathological findings have been published for one o f the cheetahs (Peet and Curran
1992) and one o f the pumas (Willoughby et al. 1992) which developed FSE.
The central nervous system of the cheetah was characterised by the presence of severe 
spongiform changes in the grey matter, especially in the corpus striatum, thalamic 
regions and mid-brain. The spongiform changes were characterised by the presence 
of small ovoid spaces in the neuropil and vacuolated neurons, similar to those 
described by Wyatt et al. (1991). No evidence of spongiform changes or vacuolated 
neurons was seen in the grey matter of the spinal cord. In the cheetah there was 
extensive axonal degeneration and demyelination o f all spinal cord tracts, with the 
changes extending up the pyramidal and other white matter tracts of the medulla as far 
rostral as the internal capsule region. Macrophages were visible in some of the empty 
myelin cylinders o f the spinal cord white matter.
Post mortem evaluation of the puma did not reveal any significant gross 
abnormalities, but histopathology demonstrated abnormalities throughout the 
neuroaxis. The spongiform changes were characterised by single or multiple large
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vacuoles, some of which contained floccular or globular eosinophilic material, in 
neuronal perikarya and multiple smaller, round, empty vacuoles in the grey matter 
neuropil. The vacuolation of the neuropil was most marked in the caudal colliculus 
and the granular and molecular layers of the cerebellar cortex. In the spinal cord there 
was some evidence of Wallerian type degeneration with an associated astrocytosis. 
Astrocytes and microglia were present at high concentrations in the grey matter 
neuropil o f the brain, but due to the absence o f species controls the degree o f gliosis 
could not be quantified. Further changes included occasional microglial nodules and 
occasional perivascular lymphocytes in the neuropil and meninges.
PrP (prion protein) immunostaining was performed on sections from the medulla and 
spinal cord of the puma. The PrP deposition was evident as granular deposits in the 
neuronal perikarya and grey matter neuropil. The granular PrP immunostaining in the 
perikarya appeared localised discretely in the cytoplasm in both vacuolated and non­
vacuolated neurons o f the affected grey matter areas. The immunostaining in the grey 
matter neuropil was either scattered or occasionally arranged in linear arrays 
suggestive o f deposition along cell processes. The most intense immunostaining was 
present in the reticular formation, vestibular nuclei, nucleus ambiguus and the inferior 
olives. Occasional ventral horn neurons in the spinal cord showed intense granular 
immuno staining.
1.1.5 Epidemiology
1.1.5.1 Domestic Cats
Although there are at present insufficient cases o f FSE with adequate histories to 
allow accurate analysis of the epidemiology of FSE, there is strong circumstantial 
evidence to suggest a link with BSE. This link is likely to be either through a 
common origin or from cats being exposed to BSE infected tissues or a product of 
BSE infected tissues. Certainly the temporal and geographic occurrence o f FSE 
suggests an origin from BSE rather than scrapie (Bradley 1997). The weight of 
evidence suggests that the source o f infection in cats is likely to be related to the 
feeding o f BSE-contaminated feed. The quantification of the relative risks of 
different components of the diet of domestic cats has not been possible as the feed 
intake o f these cats tends to be much more variable as a result of their free ranging 
nature. A number of studies have demonstrated a link between the agent causing
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BSE, new variant CJD (vCJD), FSE and the TSE’s of exotic ungulates in the UK. 
This agent appears to be distinct from that causing iatrogenic and sporadic CJD. One 
study included evaluation of two dairy farmers with sporadic CJD, who had recorded 
cases o f BSE in their cattle herds (Collinge et al. 1996).
Transmission of FSE to mice (Fraser et al. 1994) has demonstrated similar incubation 
periods, lesion profile and percentage of affected mice as that o f BSE but distinct 
from that o f scrapie. The authors concluded that FSE and BSE are likely to have 
arisen from a similar source.
Western blots of PrPSc after proteolytic cleavage, in the sporadic and iatrogenic forms 
of CJD, allow differentiation between the type-1, type-2 and type-3 forms by 
evaluation of different band sizes. Type-4 CJD, or vCJD, while having similar band 
sizes to type-3 CJD, can be clearly distinguished from the other three forms of CJD by 
a characteristic pattern of band intensities (Collinge et a l  1996; Aguzzi and 
Weissmann 1996). Similar western blot analysis of BSE, naturally occurring FSE and 
experimental BSE in a macaque revealed an almost identical pattern of band 
intensities, which was distinct from that o f type-1, type-2 and type-3 CJD. From this 
it was concluded that vCJD, BSE and FSE are all due to infection from a common 
source, with the same strain of PrPSc.
Differentiation between the different strains o f agent which cause the TSE’s can be 
achieved by the disease characteristics they cause in experimentally infected animals, 
in particular, the incubation period and neuropathology (including the lesion profile of 
spongiform changes and distribution of PrPSc within the central nervous system). A 
study by Bruce et al. (1997) demonstrated striking similarities in the lesion profile for 
RIII mice after transmission into panels of these mice of new variant CJD from three 
cases, BSE from four cattle, FSE from two cats and a spongiform encephalopathy 
from a nyala and a kudu. This lesion profile was distinct from that generated by 
transmission into panels of these mice of scrapie from six sheep and sporadic CJD 
from two cases. As a further part of the same study, which is still on-going, a strong 
correlation has been demonstrated between the incubation periods in four strains of 
mice after transmission of vCJD from three sources, BSE from eight sources and FSE 
from two sources. This correlation is again distinct from that obtained by 
transmission of scrapie from six sources into the same panel of mice. The authors 
concluded that it is likely that the same agent strain is responsible for vCJD, BSE, 
FSE and the TSE in captive exotic ungulates in the UK.
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In the single case report from Italy (Zanusso et al 1998) the authors suggest that this 
case of FSE differs from other reported cases. They suggest that the source may be 
either an example of horizontal transmission from the owner (who was diagnosed as 
suffering from the sporadic form of CJD), infection from an unknown source or the 
chance occurrence of sporadic FSE in a cat. As evidence o f this they described a 
differing clinical presentation, uncharacteristic neuropathology and the presence of 
type-1 PrPSc, rather than the expected BSE-associated type-4 PrPSc.
1.1.5.2 Captive Wild Felidae
Due to the controlled environment and feeding history o f the captive wild felidae the 
probable source of infection can be more clearly defined. The documented diet o f the 
captive puma with FSE (Willoughby et al., 1992) consisted of chicken and rabbit 
carcasses and parts o f cattle carcasses fed fresh. The cattle material all came from a 
single supplier and consisted o f meat on the bone including split spinal columns, but 
not offal as the puma appeared to find these unpalatable. The puma additionally 
occasionally caught and ate wild pigeons, rodents and insects and on one occasion 
(three months before the development o f clinical disease) was given meat from a cull 
o f two eland from within the collection.
Dietary details are available from three o f the first four cases o f FSE reported in 
cheetahs (Kirkwood and Cunningham 1994). Two were fed horse meat and cattle 
parts, including entire or split spinal columns, as part o f their diet. The third case was 
occasionally fed entire stillborn calves in addition to a variety o f cattle and horse 
meat, although no spinal columns from adult animals were included in this cheetah’s 
diet. It is interesting to note that the cheetah that was exported to Australia and 
subsequently developed FSE left the UK 26 months prior to the first clinical signs 
attributable to FSE (Peet and Curran 1992). This would imply that if  that cheetah had 
contracted the disease in the UK, as is believed, then the incubation period must have 
been at least 26 months.
The first two cheetahs to develop clinical signs of FSE did so in 1992, with the third 
and fourth cases occurring in 1993. The captive adult puma described by Willoughby 
et al. (1992) developed clinical signs in 1991. Numbers o f species and individual 
animals kept by the National Federation of Zoological Gardens o f Great Britain and 
Ireland are available for the 31st o f December 1989 (Bennett 1990). At that time 
(Kirkwood and Cunningham 1994) there were 23 different species o f Felidae being
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kept, including populations o f 16 pumas (Felis concolour) and 42 cheetahs (Acinonyx 
jubatus).
1.1.6 Control
The control methods suggested assume that FSE originates from a feed source and 
that no other origin of the disease exists. The basis o f disease control involves 
implementing an effective ban on the entry o f specified bovine offal into cat feed, or 
by ensuring adequate processing o f potentially infected bovine tissues before use in 
cat feed. The carcasses o f affected cats should be disposed o f safely, preferably by 
incineration, and there should be no risk o f their entering the food chain. Bradley 
reported in 1997 that so far no case of FSE had been reported in a cat bom after the 
imposition of the specified bovine offal ban in September 1990. It is now widely 
believed that an effective ban on the incorporation o f specified bovine offal to any 
species of mammal or birds was not instituted until after the recognition o f new 
variant CJD in 1996 (personal communication, Williams 1998).
Control of TSE’s in zoos in the UK and the Republic o f Ireland has been attempted by 
informing all the said zoos of the occurrence, clinical sings and pathological findings 
in exotic species. Zoo authorities have been made aware o f the potential risks in 
exporting animals and attempting to release animals back into the wild.
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1.2 Review of Transmissible Spongiform Encephalopathies in Animals
1.2.1 Scrapie
Scrapie was the first transmissible spongiform encephalopathy to be reported in 
animals, having been described in England as early as 1732. It affects sheep and 
goats (although less common in goats) (Harcourt and Anderson 1974), and in the UK 
has been reported to occur in moufflon (Ovis musimon), a primitive breed of sheep 
(Wood et al. 1992). It has been diagnosed in all o f the major sheep raising areas of 
the world except Central America and the Caribbean, although it has successfully 
been eradicated from Australia, New Zealand and possibly some European countries 
(Bradley 1997).
1.2.1.1 Epidemiology
The epidemiology of scrapie appears to be more complex than that of the other 
transmissible spongiform encephalopathies. This is in part due to the sheep sip gene, 
which plays an important role in determining susceptibility, and partly due to the 
apparent absence of a dietary origin. Investigations into transmission of A-group and 
C-group strains of scrapie have demonstrated that the polymorphisms of the two 
domains of the PrP gene, codons 136 (valine versus alanine) and 171 (arganine versus 
glutamine), determine the relative susceptibility to different scrapie strains. These 
susceptibility effects reverse between A-group and C-group strains of scrapie 
(Bradley 1997).
The demonstration o f susceptibility effects is of significance as they allow selection of 
sheep with low susceptibility for the scrapie agent (Dawson et al. 1998). That these 
susceptibility effects reverse, depending on whether the scrapie strain is of the A- 
group o f C-group is important, as the field scrapie strain has to be determined prior to 
selection. Additionally, if  a ram, with the opposite PrP gene polymorphisms, is 
introduced into a flock resistant to the local strain of scrapie, offspring susceptible to 
the local strain o f scrapie will be bred. If these offspring are kept for breeding stock 
an apparent outbreak of scrapie will occur. This explains outbreaks o f scrapie in an 
apparently scrapie-free flock where a new ram, itself from a scrapie-free flock, was 
introduced.
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Infectivity has been demonstrated in the placenta (Pattison et al. 1974), CNS and 
lymphoreticular systems, but no other tissues have been demonstrated to be infective, 
including semen, skin and a variety of other bodily fluids and tissues (Hadlow et al. 
1982). Once a scrapie-infected sheep has been introduced into a flock there is rapid 
horizontal spread and evidence of vertical spread. The source o f the horizontal 
transmission may be through eating infective placentas and contamination of pastures 
with the infective agent (through contact with infected placentas).
1.2.1.2 Clinical presentation
The clinical signs associated with scrapie are variable and animals do not necessarily 
display all the clinical signs (Clark and Moar 1992). Scrapie may cause sudden death, 
without preceding clinical signs (Clark et al. 1994). The disease is characterised by 
an insidious onset, with gradual progression, resulting in death a few weeks to months 
after the first clinical signs were noticed.
The first clinical sign to be noticed is altered behaviour. Affected sheep will tend to 
lag behind or walk ahead o f the flock and may not respond normally to sheep dogs. 
Pruritis, from where the disease’s name is derived, is the main feature of the disease 
once it is fully established, although this is not a consistent finding. The pruritis 
manifests as scratching against objects, biting and in homed breeds, using their homs 
to scratch their flanks and backs (Linnabary et al. 1991). Ataxia, hypermetria and 
hyperaesthesia may also be present (Bradley 1997). Decreased rumination has been 
reported, although feeding is normal and the majority of sheep display polydipsia and 
polyuria (Austin and Simmons 1993).
1.2.1.3 Pathology
Scrapie displays all the classical features o f a transmissible spongiform 
encephalopathy with vacuolation of the neuronal cytoplasm and grey matter neuropil, 
marked astrocytosis, neuronal cell loss and amyloidosis. Particularly apparent is the 
neuronal cytoplasmic vacuolation, particularly in the mid-brain, pons, medulla and 
ventral and lateral grey matter of the spinal cord (Bradley 1997). Amyloid plaques 
were present in over 50% of cases (Gilmour et al. 1985). In a review of brains, 
affected by sheep scrapie, submitted to the Central veterinary Laboratory in 
Weybridge, certain breed specific patterns of disease were apparent.
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1.2.2 Bovine Spongiform Encephalopathy
BSE was first reported in 1987 in the UK as a novel disease (Wells et al 1987), with 
the first identified case dating back to April 1995. Following this initial report 
increasing numbers o f BSE cases were reported resulting in epidemiological studies 
commencing in 1987. Cases in the UK peaked in 1992 with 36682 confirmed cases in 
that year. As o f the 13th of February 1998 a total o f 170555 confirmed cases have 
been recorded, since the start o f the BSE epidemic. In addition to the UK, BSE has 
been reported in a variety o f European countries, with (as at the 1st o f February) the 
highest number o f cases in the Republic o f Ireland (275 cases), Switzerland (272 
cases), Portugal (93 cases) and France (33 cases).
1.2.2.1 Epidemiology
Epidemiological studies have demonstrated strong circumstantial evidence that the 
BSE epidemic has arisen through feed contaminated with the infective agent. It was 
originally thought that the prion protein strain responsible for the BSE epidemic was 
as a result o f one o f the thermostable scrapie strains becoming pathogenic for cattle. 
The recycling o f cattle and sheep carcasses into cattle feed in the form o f meat and 
bone meal led to the perpetuation o f the epidemic.
A possibility is that the BSE agent may originally have arisen from a single case of 
sporadic BSE (similar to sporadic CJD in humans), that subsequently found its way 
into the cattle feed chain as meat and bone meal. Supporting this is that the BSE 
strain does not resemble the 20 scrapie strains to which it has so far been compared, 
although there is still a possibility that BSE may have arisen from a less common, but 
more thermostable, scrapie strain (Bruce et al 1997). The change in the method of 
processing o f the meat and bone meal immediately preceding the BSE epidemic was 
originally suspected to be the cause o f the epidemic, which may have allowed a more 
thermostable strain o f scrapie to survive at an infective level. This theory has been 
refuted (Taylor 1996) with no demonstrable difference in the level o f infectivity of 
feed samples derived from different processing methods.
Transmission studies have demonstrated that oral transmission o f the BSE agent is 
feasible and the experimental host range o f the BSE agent via the oral route includes 
sheep, goats, mice, mink (Bradley 1997) and calves (Matthews 1996). Experimental 
transmission via the parenteral route has been demonstrated in cattle, sheep, goats, 
pigs, mice, marmosets and mink, but not in hamsters and chickens (Bradley 1994;
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1997; Dawson et a l  1990). Studies (Bruce et a l  1997; Collinge et a l 1996) have 
demonstrated that the agent strain responsible for BSE is similar to that causing new 
variant CJD, FSE and the spongiform encephalopathies o f captive exotic ungulates in 
UK zoos, and distinct from agent strains resulting in sporadic CJD and of the scrapie 
strains tested to date.
Identification o f the BSE epidemic and the linkage to the feeding of meat and bone 
meal led to the introduction o f the ruminant feed ban o f July 1988 in the UK. By 
1996, 27000 cases o f BSE, bom after the introduction o f the feed ban, had been 
identified in the UK (Matthews 1996). Some o f these cases can be ascribed to the 
continued feeding o f meat and bone meal, which had been stockpiled before the ban 
was introduced. Identification o f cross contamination of ruminant feed in feed mills 
with meat and bone meal destined for poultry and pigs led to increased controls being 
introduced in 1995 and 1996. This included the introduction o f a complete ban on the 
use o f mammalian meat and bone meal on farms and for feeding food producing 
animals, horses and farmed fish. As a result o f the control measures, the number of 
confirmed cases has dropped from 2000 a week at the height o f the epidemic to below 
200 a week at present.
1.2.2.2 Clinical presentation
BSE is a progressive disorder which eventually results in extreme loss of condition, 
paraplegia and is invariable fatal. Following the widespread knowledge about BSE, 
the disease is now usually identified early on and affected animals are euthanased 
before displaying advanced clinical signs. The clinical features associated with BSE 
(Wilesmith et a l 1992) include the development of altered behaviour, altered 
sensation, bradycardia (Austin et a l 1996), decreased rumination (Austin and 
Simmons 1993) and postural abnormalities. The clinical features are often 
exacerbated by stress, explaining the higher incidence associated with calving and 
management changes.
Not all the clinical features are present in every case. The behavioural changes 
include the development of frenzy, nervousness o f entrances, teeth grinding, abnormal 
ear position, inappropriate behaviour, altered temperament and apprehension. Altered 
sensation is apparent as blindness, head pressing or rubbing, head shyness, excessive 
licking, kicking in the milking parlour and hyperaesthesia. The postural abnormalities
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that may be apparent include ataxia, paresis, tremors, abnormal head carriage, falling, 
recumbency, knuckling on the fetlocks and circling.
1.2.2.3 Pathology
The pathology associated with BSE is characteristic of the transmissible spongiform 
encephalopathies and includes vacuolation o f the grey matter neuropil, single or 
multiple vacuoles in the neuronal perikarya (Wilesmith and Wells 1991), astrocytosis 
seen as astrocyte hyperplasia (Wells et a l  1991), neuronal cell loss and the presence 
of PrPSc. The neuronal cell loss is most noticeable in the vestibular cell complex 
(Jeffrey 1992). The single strain hypothesis has been supported by the extremely 
consistent distribution o f the spongiform changes seen throughout the BSE epidemic 
(Bruce et a l  1994; Simmons et a l  1996). This consistency of distribution o f the 
spongiform changes allows reliable diagnosis o f BSE on a single section o f the 
medulla through the obex (Wells et a l 1989) and a suitable sample can be collected 
through the foramen magnum, therefore reducing costs and improving safety.
Lesion profiles performed on at least a thousand random BSE cases taken at two 
different time-periods during the BSE epidemic have been published (Simmons et a l  
1996). A summary of these findings is included in Figure 1.
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Figure 1 BSE lesion profile in domestic cattle in the UK (adapted from Simmons et 
al. 1996)
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15. caudate nucleus
16. putamen
17. claustrum
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1.2.3 Spongiform Encephalopathies of Exotic Ungulates in the UK
Associated with the BSE epidemic, spongiform encephalopathies have been 
diagnosed in a number of captive exotic Bovidae kept in British zoos. As at the 1st of 
January 1998, six kudu, one gemsbok, one nyala, two oryx and six eland have been 
diagnosed with spongiform encephalopathies. Epidemiological and transmission 
studies are consistent with the spongiform encephalopathy in these animals being 
related to the BSE epidemic.
1.2.3.1 Epidemiology
The source of the infectious agent in these cases is likely to be through contaminated 
feed, although in one case (Kirkwood et al. 1992) there was no evidence o f an 
affected greater kudu having direct exposure to contaminated feed, although this 
animal’s dam had died of a spongiform encephalopathy. Epidemiological analyses 
have demonstrated a link with BSE. Firstly the temporal and geographic occurrence is 
identical to that of BSE. Secondly in all the affected animals where details are 
available there was either direct exposure to potentially contaminated feed, or the 
affected animal was bom into a herd which had been exposed to potentially 
contaminated material (Kirkwood and Cunningham 1994a). Thirdly transmission of 
brain homogenate from one affected kudu and the affected nyala into mice resulted in 
a similar pattern of neuropathological changes to that of BSE (Bmce et al. 1997). 
Based on the suspected dietary origin of the disease, control in the EU has been 
instituted under the ban on feeding mammalian protein to ruminant animals.
1.2.3.2 Clinical presentation
The disease course in all the affected animals was reasonably rapid, varying from 
seven to fifty-six days. Two of the kudu were culled for managemental reasons 
before they were demonstrating any clinical signs and a diagnosis of a spongiform 
encephalopathy was made on post-mortem examination. The clinical presentation 
varied in the affected species, from episodic collapse in the gemsbok, to more 
classical sings of dullness, drooling, muscle tremor, hypermetria and ataxia. Not all 
the kudu demonstrated all the clinical signs, but all o f the clinically affected kudu had 
the presence o f a head tilt (Bradley 1997; Kirkwood and Cunningham 19946).
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1.2.3.3 Pathology
In all the spongiform encephalopathies o f captive wild Bovidae, the pathology 
resembles that of BSE. In the nyala (Jeffrey and Wells 1988) the vacuolation o f the 
neuropil was most severe in the medulla, diminishing rostrally and caudally, although 
changes were present as far cranial as the hippocampus. In particular, the dorsal 
nucleus of the vagus nerve and nucleus o f the spinal tract o f the trigeminal nerve were 
severely affected. Cytoplasmic neuronal vacuolation was demonstrated in the dorsal 
nucleus of the vagus nerve. No astrocytosis and no amyloid plaques were 
demonstrated. The neuropathology in the other species was similar, although the 
severity o f the changes in the brain stem o f the oryx was less severe (Bradley 1997).
1.2.4 Spontaneous Spongiform Encephalopathies of Captive Primates 
Spongiform encephalopathies have been diagnosed in a two lemurian zoo primates 
(Eulemur fulvus mayottensis) (Bons et al. 1997) and three rhesus monkeys (Macaca 
mulatto) (Bons et al. 1996). In all cases the affected animals were maintained on a 
diet containing animal protein (including a bovine source), which would suggest that 
the spongiform encephalopathy in these animals is related to the BSE epidemic.
1.2.4.1 Epidemiology
The source o f the infectious agent in these cases is likely to be through contaminated 
feed, although no confirmatory epidemiological evidence has been published. All o f 
the affected animals were maintained on a diet containing animal protein. The three 
rhesus monkeys came from the same zoo and all the cases originated from zoological 
gardens in France.
1.2.4.2 Clinical presentation
The clinical presentation in both species was characterised by the development o f 
dramatic neurological signs. The affected rhesus monkeys presented with a 
progressive neurological disorder with behavioural abnormalities. The affected 
individuals deteriorated physically and died.
1.2.4.3 Pathology
A detailed pathological examination was performed on one rhesus monkey with the 
reported changes similar to those seen in monkeys following experimental 
transmission o f CJD. The changes were characterised by an astrocytosis and
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vacuolation of neuronal cell bodies and processes. The disease-related isoform of 
PrP, PrPSc, was demonstrated by immunocytochemistry.
In the lemurians, microscopy o f the brain revealed vacuolation o f neurones with 
demonstration of the disease related isoform of PrP by immunocytochemistry. In the 
lemurians, in addition to the demonstration o f PrPSc in the brain, prion 
immunoreactivity was demonstrated in the tonsils, gastrointestinal epithelial cells and 
blood and lymph vessels.
1.2.5 Transmissible Mink Encephalopathy
Transmissible mink encephalopathy (TME) is a spongiform encephalopathy affecting 
ranch-raised, adult mink. The disease was first described in 1947 in the USA and has 
since been described in Finland, Germany and the former Soviet Union (Summers et 
a l  1995).
1.2.5.1 Epidemiology
Scrapie-contaminated products of sheep and goats are though to be the source of 
infection in transmissible mink encephalopathy, although this has not definitely been 
confirmed. In one reported outbreak of TME (Marsh et al. 1991), the mink on the 
affected ranch were fed only on food derived from cattle sources, predominantly from 
sick and downer cows, in the absence of any sheep or goat-derived feed products. 
Transmission studies in this outbreak demonstrated that the disease could be 
transmitted from the mink to bull calves by intracerebral injection, and back into 
mink, raising the question whether there is a sub-clinical spongiform encephalopathy 
in cattle in the USA. Experimental inoculation of central nervous system (CNS) 
tissue from transmissible mink encephalopathy cases into goats and various strains of 
mice (Barlow and Rennie 1970) resulted in the development o f a disease that was 
clinically and pathologically indistinguishable from Scrapie. Transmission of TME 
into hamsters has lead to the identification of two distinct strains of the causative 
agent, namely hyper (HY) and drowsy (DY), based on biological properties (Bessen 
and Marsh 1992). The introduction o f infection into a group o f mink is likely to be 
through contaminated feed, but whether the route of infection is through oral 
ingestion or intradermal inoculation as a result o f fighting is unclear. Additionally the 
role of cannibalism in the spread of the disease is not clear.
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1.2.5.2 Clinical presentation
Based on experimental and epidemiological information the incubation period has 
been determined to be in the region o f eight to twelve months (Summers et a l  1995). 
The disease is characterised by a relatively short clinical course of a few weeks, 
although this can vary. Initially the mink display behavioural abnormalities, 
including the development o f aggression, hyperexcitability and hyperaesthesia as well 
as inappropriate defecation and feeding patterns, resulting in soiling o f their coats and 
loss of condition. The behavioural abnormalities are initially relatively subtle and are 
followed by the development o f progressive ataxia, debilitation, somnolence and 
eventually death. Blindness in the terminal stages is common. In some cases self- 
mutilation occurs and this may be severe enough to result in death due to blood loss 
(Bradley 1997).
1.2.5.3 Pathology
Pathologically the appearance is that o f a classical spongiform encephalopathy with 
bilaterally symmetrical grey matter spongiform changes and an astrocytosis. The 
most marked changes are found in the prosencephalon, particularly in the gyri o f the 
frontal lobes, the amygdaloid nucleus, corpus striatum and thalamus. The spinal cord 
and cerebellum are usually spared (Bradley 1997; Marsh and Hadlow 1992).
1.2.6 Chronic Wasting Disease
Chronic wasting disease is a transmissible spongiform encephalopathy which has 
been reported to affect mule deer (Odocoileus hemionus hemionus), Rocky Mountain 
elk (Cervus elaphus nelsoni), black tailed deer (Odocoileus hemionus columbianus) 
and hybrids of captive mule deer and white-tailed deer {Odocoileus virginianus) in 
wildlife facilities in Colorado and Wyoming (Williams and Young 1980; 1982). The 
disease was first recognised in 1967 in captive mule deer.
1.2.6.1 Epidemiology
Epidemiological analyses of data from facilities for captive deer and elk in Wyoming 
and Colorado have demonstrated no evidence that chronic wasting disease is related 
to a dietary origin. The disease is though to be spread via horizontal contact. Vertical 
transmission may play a role, but does not explain the cross species transmission that 
has been reported. Experimentally, the disease has been successfully transmitted to
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other deer and ferrets, but the primary source o f the disease is not known (Williams 
and Young 1982; 1992; Spraker et a l  1997).
1. 2.6.2 Clin ical presen tation
The disease in both deer and elk is characterised by being chronic and progressive 
over a period of several months, with affected animals usually in the 3 to 5 year age 
range (Summers et a l  1995). In both deer and elk the clinical signs are characterised 
by weight loss, teeth grinding, behaviour abnormalities (including decreased 
association with other animals in the same group and keepers, blank appearance and 
increased somnolence), excessive salivation and is invariably fatal. In deer, additional 
clinical signs that are evident include polyuria and an underlying polydipsia, difficulty 
swallowing, oesophageal dilation, regurgitation and aspiration pneumonia (usually 
occurring terminally). In elk, in addition to the clinical signs discussed above, 
hyperaesthesia and hyperexcitability are common and hind limb ataxia is occasionally 
seen (Bradley 1997).
1.2.6.3 Pathology
The pathological distribution is similar to that o f scrapie and BSE, with spongiform 
changes of the neuropil, single or multiple intracytoplasmic vacuoles in the neuronal 
perikarya and associated astrocyte hyperplasia and hypertrophy (Guiroy et al. 1993). 
The spongiform changes o f the neuropil are especially evident in the spinal cord grey 
matter, medulla oblongata, pons, mesencephalon, thalamus, hypothalamus, cerebral 
cortex and cerebellar cortex. In some cases amyloid plaques have been demonstrated 
in association with the other CNS lesions (Guiroy et a l  1991a, b). These amyloid 
plaques are readily visible in deer on routine histopathological examination, but in elk 
are only demonstrable by PrP immunocytochemistry.
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1.3 Review of Transmissible Spongiform Encephalopathies in Humans
A number of human varieties of TSE’s have been described, including Kuru, CJD, 
Gerstmann-Straussler-Scheinker Disease (GSSD or GSS), Fatal Familial Insomnia 
(FFI) and atypical prion dementias. The human TSE’s can be divided into three 
categories: inherited, acquired and sporadic forms. Recently, a new form of CJD, 
vCJD, has been identified with an age of onset, pathology and clinical picture distinct 
from the other forms of CJD. There is strong evidence linking vCJD to the recent 
BSE epidemic.
1.3.1 Inherited TSE’s
The development of molecular genetics has identified specific mutations associated 
with the inherited TSE’s, allowing molecular classification of the different syndromes 
in addition to the traditional phenotypic distinctions. These diseases are now 
preferentially referred to as inherited prion diseases. Furthermore, the recognition of 
specific mutations has allowed classification o f phenotypes that are not easily 
allocated under the existing descriptions of CJD and GSS. It has provided an 
explanation of families where CJD and GSS syndromes co-exist and has allowed 
demonstration of prion diseases in the absence of characteristic pathology (Collinge at 
al. 1990). Once disease has developed due to the presence o f a mutation in the human 
PrP gene it can be transmitted by iatrogenic and experimental means.
The human PrP gene is a single copy gene spanning 16kb and containing two exons, 
located on the short arm of chromosome 20. The complete open reading frame o f 759 
nucleotides is found in the larger second exon, which comprises the majority o f the
2.4 kb mRNA. Both the familial forms of CJD and GSS have an autosomal dominant 
pattern of disease segregation. The mutations described to date in the human PrP 
gene can be classified into two groups (Collinge and Palmer 1997):
1. Point mutations within the coding sequence resulting in the substitution of amino 
acids in the PrP sequence or in one case the production o f a stop codon resulting in 
the expression of a truncated form of the normal protein.
2. Insertional mutations, with additional integral numbers o f repeat elements within 
the normal series of tandem octapeptide repeats near the N terminal.
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1.3.1.1 Common phenotypes associated with PRNP mutations
Although a variety o f atypical phenotypes have been described, including atypical 
prion dementias and peripheral neuropathies the three main phenotypes are CJD, GSS 
and FFI.
1.3.1.1.1 CJD phenotype
The classic clinical presentation for CJD (Collinge and Palmer 1997) is a rapidly 
progressive multifocal dementia with myoclonus. Frequently, pyramidal, cerebellar 
and extra-pyramidal signs are present. The clinical course is rapid with progression to 
akinetic mutism and finally death. The duration o f illness is usually less than 12 
months, with many cases dying within two to three months. The age o f onset of 
clinical disease is advanced, for example, in the PrP Glu200Lys mutation the average 
age of onset is 55 years (Brown et a l  1992a). The inherited forms o f CJD do not 
usually display the characteristic EEG changes seen in sporadic CJD, although the 
neuropathology is typical. CJD is characterised by the presence of spongiform 
changes, neuronal loss and an astrocytosis, but PrP amyloid plaques are absent. 
Protease resistant PrP can be demonstrated by immunoblotting of brain homogenates 
(Collinge and Palmer 1997).
1.3.1.1.2 GSS phenotype
GSS is characterised by a chronic cerebellar ataxia with pyramidal features 
(Seitelberger 1962). The development o f dementia tends to occur later and the 
disease has a much more prolonged clinical course than CJD. Onset o f clinical signs 
is usually in the region of 30 to 50 years, with the mean duration being about five 
years. In addition to the spongiform change, neuronal loss, astrocytosis and white 
matter loss, typical o f the prion diseases, there are multicentric amyloid plaques.
1.3.1.1.3 FFI phenotype
The first reported cases o f FFI described a rapidly progressive disease with 
unbeatable insomnia, dysautonomia and motor signs (Lugaresi et al 1986; Medori et 
a l 1992a, b). Neuropathological changes are characterised by selective atrophy of 
the anterior-ventral and medio-dorsal thalamic nuclei, marked thalamic astrocytosis, 
mild spongiform changes in some cases and the presence o f protease-resistant PrP by 
immunoblotting.
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1.3.1.2 Genotypes associated with PRNP mutations
The reported genotypes have been listed and only those of particular interest or 
relevance are discussed in more detail.
1.3.1.2.1 Polymorphic variations in PRNP which are not associated with clinical 
disease
A number o f polymorphic variations in the human PrP gene (PRNP) have been 
described which have not been associated with clinical disease. These include: PrP
1 9QMet Val (which has an important role in selection of susceptibility , selection o f the 
individual phenotype and determination of the age o f onset of the respective 
spongiform encephalopathies); PrP GGC124GGG (Hsiao et al. 1992; Collinge and 
Palmer 1997); PrP GCAU7GCG (seen in 2.5% of Caucasians), PrP CAC177CAT
9 1 0  •(Ripoll et a l 1993); PrP Glu“ Lys (occurring at an allele frequency of about 6%in the 
Japanese population) (Furukawa et al. 1995); and a PrP 24 bp deletion (one less 
octapeptide repeat) (Laplanche et a l 1990; Palmer et a l  1993).
1.3.1.2.2 Missense Mutations
The site of reported point mutations within the coding sequence o f the human prion 
protein gene, the amino acid substitutions involved and the reported associated 
clinical syndrome are shown in Figure 2.
1. PrP Pro102Leu (Hsiao etal. 1989)
2. PrP Pro105Leu (Kitamoto et al 1993b)
3. PrP Ala117Val (Dohura et al. 1989; Hsiao etal. 1991; Collinge and Palmer 1997)
4. PrP Tyr145STOP
This mutation is of interest because it results in the formation o f a truncated form of 
the PrP protein. The investigators demonstrated that the truncated form of PrP was 
expressed, but more importantly, all deposited PrP consisted o f the truncated form 
with none of the wild type present. This is consistent with the belief that for 
successful interaction of the host PrP with the PrPSc the two proteins should be 
homologous (Kitamoto et a l 1993a).
5. PrP Asp178Asn
The original described mutation resulted in a CJD-like phenotype (Goldfarb et a l 
1991 b). Subsequently, it has been demonstrated that this mutation is also 
responsible for Fatal Familial Insomnia (FFI) (Lugaresi et a l 1986; Medori et a l
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1992a,b). To date all the cases demonstrating the CJD-like phenotype have the 
mutation on a valine 129 allele, while all the FFI-type phenotypes have the 
mutation on a methionine 129 allele (Goldfarb et al. 1992). The 129 allele appears 
to select the phenotype o f the mutation. Further studies are needed to ensure that 
the CJD and FFI phenotype are not just extreme ends o f the normal disease 
spectrum. An alternative explanation is that the presence o f the valine or 
methionine 129 allele may be due to the selection o f related subjects for the study, 
who incidentally have that respective coding on the 129 allele. Western blot 
analysis of proteinase K treated PrP, extracted from these cases has demonstrated 
different sized PrP bands, suggesting that these FFI and CJD cases may be related 
to different forms of PrPSc (Monari et a l  1994).
6. PrP Val180Ile (Farlow et al. 1989; Ghettie et al. 1989; Kitamoto et al. 1993b).
7. PrP Phe198Ser (Farlow et al. 1989; Dlouhy et al. 1992)
Codon 129 appears to play a role in age of onset in this disease, with individuals 
heterozygous at this site having a later onset o f clinical disease than homozygous 
individuals.
8. PrP Glu200Lys (Golfarb et al. 1990; Brown et al. 1992a)
Since the development of PrP gene analysis, further cases o f this mutation with an 
atypical clinical presentation (including a peripheral neuropathy) have been 
described (Neufeld et al. 1992).
9. PrP Arg208His (Mastrianni et al. 1995)
This mutation has been identified in a single patient with CJD, with no published 
clinical or pathological history.
10.PrP Val210Ile (Davies et al. 1993)
11 .PrP Gln217Arg (Hsiao et al. 1992)
12.PrP Met232Arg (Kitamoto etal. 1993b)
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Figure 2 Structure of the 253 amino acid human prion protein illustrating the site of 
reported amino acid substitutions and the clinical syndrome with which they have 
been associated. Modified from Collinge and Palmer (1997).
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1.3.1.2.3 Insertional Mutations
The 253 amino acid human prion protein and sites of insertion of additional integral 
numbers of repeat elements within the normal series of tandem octapeptide repeats 
near the N terminal is shown in Figure 3.
1. PrP 24 bp insertion (one extra repeat) (Laplanche et al. 1995)
2. PrP 48 bp insertion (two extra repeats) (Goldfarb et al. 1993).
3. PrP 96 bp insertion (four extra repeats) (Laplanche et a l 1995; Campbell et al. 
1996; Goldfarb et al. 1991a)
4. PrP 120 bp insertion (five extra repeats) (Goldfarb et al. 1991a)
5. PrP 144 bp insertion (six extra repeats) (Owen et al. 1989; Meyer et al. 1954; 
Collinge et al. 1990).
Codon 129 determines the age o f onset in this mutation. As the mutation occurs on a 
methionine 129 PrP allele, affected individuals may either be methionine 129 
homozygotes or methionine 129/valine 129 heterozygotes. Heterozygous 
individuals have an age of onset about a decade later than homozygous individuals 
(Poulter et al. 1992).
6. PrP 168 bp insertion (seven extra repeats) (Goldfarb et al. 1991a)
7. PrP 192 bp insertion (eight extra repeats) (Goldfarb et al. 1991 a)
8. PrP 216 bp insertion (nine extra repeats) (Owen et al 1992; Krasemann et al. 1995)
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Figure 3 Structure of the 253 amino acid human prion protein demonstrating the site 
of insertion of additional integral numbers of repeat elements within the normal series 
of tandem octapeptide repeats near the N terminal. Modified from Collinge and 
Palmer (1997).
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1.3.2 Acquired TSE’s
13.2.1 Kuru
This disease of the Fore people in the highland rain forests o f Papua New Guinea was 
first described by Gajdusek and Zigas while they were trekking there (Gajdusek and 
Zigas 1957). The highlands were unknown to the outside world until 1930 and 
administrative contacts started in the 1950s. There is reason to believe that the 
disease first appeared in the early part of this century and gradually increased to near 
epidemic proportions by the mid 1950s, at which stage the annual mortality was 
approximately 200 (Collinge and Palmer 1997). The disease affected only members 
of the Fore linguistic group and, to a lesser degree, the surrounding tribes with which 
they intermarried.
1.3.2.1.1 Clinical presentation
Kuru is the native word for shivering and describes the fine tremor o f the head, trunk 
and limbs which is associated with a gradual onset o f ataxia. The disease is 
progressive, with patients initially displaying prodromal signs including headaches 
and joint and limb pain, followed by the development o f cerebellar signs and finally 
by hypotonia, hyporeflexia and brain stem signs. Death is usually as a result of 
bronchopneumonia and respiratory failure.
A feature of the disease is the development of behavioural changes (mood changes 
and hilarity). Due to the bizarre uncontrollable laughter the disease has been termed 
‘the laughing death’.
1.3.2.1.2 Epidemiology
The disease predominantly occurred in young adult women and children (over four 
years of age) of both sexes and this originally led the investigators to suspect either a 
sex-linked genetic abnormality or an endocrine disorder. Only about 2% o f the cases 
occurred in adult males (Alpers 1987). The epidemiology of Kuru is interesting in 
that the disease occasionally occurred in clusters, with several members o f the same 
clan developing Kuru within several months of each other.
About ten years after the development of formal administrative contacts the disease 
had disappeared in children under 10 years of age (Gajdusek et al. 1966). This 
decrease in incidence in the younger age groups continued after the banning of the
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ritual cannibalism by the administration, with no new cases reported in children bom 
after 1956 (Collinge and Palmer 1997). The decline in incidence associated with the 
ban on ritual cannibalism led to further investigation into a possible link between the 
two. The ritual form of cannibalism practised by the Fore people was performed as a 
mark of respect to dead relatives. As part of this ritual it was customary for the 
remaining members of the community to consume the dead relative. The men would 
eat the meat while leaving the remainder of the body, including the brain to the 
women and children. The infectious agent has been demonstrated in a high titre in 
brain tissue, but almost never in muscle tissue (Brown 1980) explaining the higher 
incidence in children and women. Apart from the actual consumption of the brain 
tissue, the preparation o f the cadaver by the women and children would put them at 
further risk of exposure. The liquefied brain tissue was scooped by hand into bamboo 
cylinders for preparation and therefore additionally exposed the women and children 
to the risk of intradermal (scratching insect bites) and conjunctival (rubbing eyes) 
exposure to the infectious agent (Collinge and Palmer 1997).
After a lengthy period o f unsuccessful transmission studies using rodents, the disease 
was finally transmitted to a chimpanzee in 1965 (Gajdusek et al 1966). Further 
experimental transmission using the oral route was successful (Gibbs et al. 1980). 
The origin of Kuru in this region was thought to be due to the development o f a single 
sporadic case of CJD in the region in the early part o f the century (Collinge and 
Palmer 1997). The occurrence of clusters of Kuru in members of the same 
community of different ages can be explained by the participation of the entire 
extended family in a ritual cannibalistic feast. An important feature to be recognised 
from the Kuru epidemic is the absence of vertical transmission, in that most of the 
children bom from affected mothers after 1956 and all o f those bom after 1959 did 
not develop Kum.
Currently 6 to 8 cases are occurring per year, all in individuals aged over 40 years, 
which is consistent with exposure prior to 1956 and indicated an incubation period 
which can exceed 40 years. The shortest calculated incubation period (based on age 
of onset of disease) was found to be 4 V2 years. Experimentally, incubation periods of 
up to eight years have been demonstrated in the rhesus monkey (Gajdusek and Gibbs 
1972).
33
Introduction: prion diseases in man
1.3.2.1.3 Pathology
The pathology of Kuru is very similar to that o f CJD (Bendheim 1984, Collinge and 
Palmer 1997). It is characterised by mild to moderate neuronal vacuolation, a marked 
reactive astrocytosis, corticospinal and spinocerebellar tract degeneration and, in at 
least half the studied cases, the presence of numerous amyloid plaques. These 
amyloid plaques are termed ‘Kuru plaques’ (Masters et al. 1981) and tend to be most 
common in the cerebellum. The similarities between Kuru and CJD prompted the 
successful experimental transmission of CJD in 1968 by Gibbs et al.
1.3.2.2 Iatrogenic CJD
The mechanism behind infection in these cases is direct bodily penetration with 
contaminated instruments or tissues. Recognised iatrogenic routes o f transmission 
include treatment with human cadaveric pituitary-derived growth hormone (Brown 
1990) or gonadotropin (Cochius et al. 1992), dura mater (Thadani et al. 1988) or 
corneal grafting (Duffy et al. 1974) and the use o f inadequately sterilised 
neurosurgical instruments (Bernoulli et al. 1977; Will and Matthew 1982).
Cases of acquired CJD arising through peripheral injection tend to have a longer 
incubation period and develop a progressive ataxia syndrome. Comparison of these 
cases with Kuru reveals similarities in both the clinical presentation and the 
incubation period. Incubation periods of 20 to 30 years between the last participation 
in ritual cannibalism and the onset of clinical signs have been documented in Kuru 
(Klitzman et al. 1984). This period is similar to incubation periods of up to 20 years 
between the last hormonal treatment and the development o f clinical signs in 
iatrogenic CJD (Brown 1988). In cases with direct intracerebral or intraocular 
inoculation of the infective agent by means o f contaminated instruments, corneal 
transplants or dura mater grafts and in experimental intracerebral inoculation in 
chimpanzees the incubation period is two years or less (Brown 1990). Additionally 
these patients tend to develop the classic form of CJD with the development o f a 
rapidly progressive dementia.
The infectivity of inadequately sterilised neurosurgical instruments is illustrated by 
the example where in 1977 two patients developed CJD 16 and 20 months 
respectively after receiving stereotactic electroencephalographic depth recordings for 
epilepsy. The same electrodes had been used earlier for stereotactic exploration of a
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CJD patient and had been sterilised with 70% alcohol and formaldehyde vapour. One 
of the electrodes was found to be still infective when implanted into a chimpanzee’s 
cerebral cortex (Bernoulli et a l  1977).
In the case of CJD developing secondary to the use of human cadaveric pituitary- 
derived growth hormone (Brown 1988) there have been about 200 cases reported 
world-wide. The relative high risk o f this group of people (around 10000 people in 
the USA and 1908 people in the UK have received this treatment) can be explained by 
the preparation o f the vials. Each batch o f growth hormone was prepared from pooled 
pituitary glands and around 2000 pituitary glands were used per batch. In addition the 
remnants of one batch were sometimes mixed with the next batch. The potential 
therefore existed for a single pituitary gland from a case o f sporadic CJD to 
contaminate a large number of vials. The cases of pituitary derived gonadotropin 
have so far been limited to patients treated in Australia (Collinge and Palmer 1997).
O f interest is the apparent genetic susceptibility to iatrogenic CJD demonstrated in the 
cases o f CJD arising from treatment with cadaveric pituitary-derived growth 
hormone. Studies performed firstly in the UK (Collinge et a l  1991) and subsequently 
in France (Laplanche et a l  1994) and the USA (Brown et a l  1992b) have 
demonstrated an excess o f codon 129 homozygotes and in particular valine 
homozygotes. When you consider that only 11% of the population are valine 
homozygotes (and for example 4 o f the 7 cases in the UK are valine homozygotes) 
this may imply that this section o f the population are at greater risk of undergoing 
conversion to the disease related isoform.
1.3.2.3 New Variant (vCJD)
With the re-institution o f CJD surveillance in the UK in 1990, as a result o f the BSE 
epidemic, three cases o f CJD with unusual clinical and pathological findings were 
reported in young individuals (Bateman et a l  1995; Britton et a l  1995; Tabrizi et a l 
1996). Included in the unusual pathological findings was the presence o f Kuru-type 
plaques. Based on further cases in 1996 vCJD was described (Will et a l  1996), the 
first reported patient developing clinical signs in February of 1994. So far, the disease 
appears to be restricted to the UK, with only a single case reported in France (Chazot 
et a l 1996), despite similar CJD surveillance programs being instituted in Europe 
(France, Italy, Germany and the Netherlands). The vCJD is characterised by (Will et 
a l 1996) a specific and apparently unique neuropathological profile, a low age of
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onset for CJD, absence o f EEG changes typical of CJD, a characteristic and protracted 
clinical course and the presence of methionine homozygosity at codon 129 of the PrP 
gene (Collinge et al 1996). Molecular analysis o f prion strain variations and 
transmission studies using mice have indicated that the prion strain which is 
responsible for the vCJD is the same prion strain responsible for BSE (Bruce et al. 
1997; Collinge et al. 1996).
1.3.2.3.1 Clinical presentation
Clinical findings in the first eight cases to die of vCJD in the UK have revealed an age 
range at death of 19 to 41 years (mean 29 years), while the interval between disease 
onset and death was 7.5 to 22.5 months (median 12 months). If these findings are 
compared to first 185 reported cases of sporadic CJD identified since starting the 
1990 CJD surveillance program, the average age of onset was found to be 65 years 
and the median duration of disease 4 months. Only two cases of sporadic CJD with 
ages of less than 45 years (both 44 years old) are included in these 185 cases (Will et 
al. 1996). O f the first ten cases of vCJD reported in the UK, nine had behavioural 
changes as an early clinical feature (initially necessitating referral to a psychiatrist) 
with dysaesthesia as a prominent feature in four cases. Nine patients developed ataxia 
as an early feature, all patients developed dementia, seven cases developed myoclonus 
(often late in the clinical course) and none of the cases displayed the characteristic 
EEG features usually associated with CJD (Will et al. 1996).
1.3.2.3.2 Pathology
The neuropathological features (Will et al. 1996; Ironside and Bell 1997) of vCJD are 
consistent and distinct from those of classical CJD with the presence o f spongiform 
changes, neuronal loss and astrocytosis especially evident in the basal ganglia, 
thalamus and focally in the cerebrum and cerebellum. The presence o f the 
spongiform changes and PrP plaques confirm the presence o f CJD. The PrP plaques 
are the most striking and consistent abnormality in these cases with the plaques being 
extensively distributed throughout the cerebrum and cerebellum with smaller numbers 
in the thalamus, basal ganglia and hypothalamus. These plaques resembled Kuru-type 
plaques with a dense eosinophilic centre and a pale periphery and usually surrounded 
by a zone of spongiform change. Examination of 175 cases of sporadic CJD did not 
demonstrate the presence of any PrP plaques. The presence of PrP plaques had only
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previously been reported in scrapie as ‘florid plaques’ and in Kuru as ‘Kuru-like 
plaques’ (Collinge and Palmer 1997).
Immunocytochemistry for PrP (Will et al. 1996; Ironside and Bell 1997) revealed a 
pericellular distribution of PrP in the cerebral cortex and the molecular layer o f the 
cerebellum (which suggested deposition around small neurons), plaques and 
pericellular deposits in the cerebrum and cerebellum (in the absence of confluent 
spongiform changes in the surrounding neuropil) and an apparent perivascular 
deposition in the basal ganglia and thalamus with resultant linear tract-like deposits.
1.3.2.3.3 Epidemiology
Analysis of risk factors in nine of the first ten cases (Will et al. 1996) revealed no 
history of potential iatrogenic exposure to CJD through neurosurgery or treatment 
with human cadaveric derived pituitary hormones. Only one patient had worked as a 
butcher and one other had visited a BSE-free dairy herd for a week a year from 1976 
to 1986. All nine of the cases had eaten beef or beef products in the last ten years, 
although none had eaten brain and one patient had been a strict vegetarian since 1991. 
Recent studies (Bruce et al. 1997, Collinge et al. 1996) have demonstrated that the 
prion strains causing vCJD, BSE, FSE and spongiform encephalopathy in two species 
o f exotic ruminants have characteristics which are identical to each other, but which 
are distinct from the strain characteristics of other forms of CJD. From these studies 
it was concluded that the PrP strain type causing vCJD, BSE, FSE and the spongiform 
encephalopathy of exotic ungulates is identical and is derived from a common source, 
most likely as a result o f BSE material entering the food chain. These studies are 
discussed in more detail in the review of FSE.
1.3.3 Sporadic TSE’s
The majority of human cases of TSE are sporadic (with, for example, only around 
15% being hereditary) and the exact aetiology o f these cases is still poorly understood 
(Bendheim 1984). The sporadic TSE’s are characterised by the absence of any 
characteristic aetiological marker but the disease can be transmitted, for example, to 
primates. In the absence o f any identifiable aetiological marker it is likely that further 
as yet unidentified forms of sporadic CJD exist with a more diverse phenotype and in 
which transmission to primates is more difficult.
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1.3.3.1 Sporadic Creutzfeldt-Jakob Disease
Sporadic CJD is the predominant human sporadic spongiform encephalopathy, with 
the other forms being classified as atypical forms of sporadic CJD.
1.3.3.1.1 Epidemiology
Sporadic CJD occurs at a frequency of approximately 0.5 to 1 per million without 
evidence of a geographic, familial or other distribution (Brown et al. 1987). There 
does appear to be a genetic predisposition for the development of sporadic CJD, with 
the majority of classical cases o f sporadic CJD being homozygous at codon 129 o f the 
PrP gene for either methionine or valine (Collinge et al. 1996). In one study of 22 
clearly defined sporadic cases o f CJD, only one patient was not homozygous for 
either methionine or valine (Palmer et al. 1991). In sporadic CJD there does not 
appear to be a coding mutation or evidence o f iatrogenic exposure, and the cases 
occur scattered throughout the population without any identifiable geographic 
distribution (apart from a frequency related to local population density) or any 
consistent associations with dietary components or occupational groups.
Of particular interest is the absence of any evidence o f case-to-case spread, besides by 
iatrogenic methods, and the absence of any correlation to the local prevalence of 
scrapie. As an example of the absence of correlation to the local incidence of scrapie, 
the incidence o f CJD in Australia and New Zealand, where scrapie has not been 
present for some years, is similar to that of the UK where scrapie is endemic (Collinge 
and Palmer 1997). Recent monitoring of all suspected cases o f CJD in the UK by 
means of the CJD surveillance unit, and in other EU countries, has led to a slight 
increase in the number of reported cases of CJD. This increase is thought to be due to 
increased awareness o f the disease rather than an actual increase. Concern about the 
occurrence o f CJD in a number o f dairy farmers in the UK being related to 
occupational exposure to BSE have been proven to be unfounded by the 
demonstration of a typical pathoclinical picture o f sporadic CJD in these cases 
(Collinge and Palmer 1997).
1.3.3.1.2 Clinical presentation
The clinical onset is between 45 and 75 years, with a peak onset between 60 and 65 
years. The clinical presentation is characterised by a rapidly progressive multifocal 
dementia, usually with myoclonus. Progression occurs over weeks with akinetic
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mutism and death often occurring within 2 to 3 months. Approximately 70% of cases 
will die in less than six months. In approximately a third o f cases prodromal signs 
can be identified, including fatigue, insomnia, depression, weight loss, malaise, 
headaches and ill-defined painful sensations. Additional neurological signs are 
frequently present and may include cerebellar ataxia, extrapyramidal signs, pyramidal 
signs and cortical blindness (Collinge and Palmer 1997).
Ante-mortal diagnosis o f CJD is difficult. Prospective epidemiological studies have 
demonstrated that cases with progressive dementia, a typical EEG and two (or more) 
of the following signs: akinetic mutism, myoclonus , cortical blindness or pyramidal, 
cerebellar or extrapyramidal signs almost always are confirmed as cases of CJD on 
neuropathological examination (Collinge and Palmer 1997). In some cases mild 
cerebral and cerebellar atrophy may be apparent on MRI and CT scans o f the brain.
1.3.3.1.3 Pathology
Neuropathologically sporadic CJD is characterised by the presence of spongiform 
changes, neuronal loss and an astrocytosis, but PrP amyloid plaques are usually 
absent. Protease resistant PrP can be demonstrated by immunoblotting o f brain 
homogenates.
1.3.3.2 Atypical forms o f Creutzfeldt-Jakob Disease
A variety of atypical forms of CJD have been described and are well recognised 
(Brown et al. 1984; Collinge and Palmer 1997).
• Approximately 10% of CJD cases have a clinical history o f longer than two years. 
These cases may represent the occasional occurrence o f CJD in individuals with 
heterozygosity for PrP polymorphism, especially at codon 129 (Collinge and 
Palmer 1997). Individuals with heterozygosity for PrP polymorphism appear to 
have a reduced susceptibility, and in those individuals that do develop CJD the 
clinical course is much more prolonged.
It appears that in heterozygotes producing two different forms of PrP there is an 
internal barrier present delaying the onset of the disease. One explanation for this 
may be due to the disease process between the PrPSc and one of the constitutional 
forms of the PrP only occurring at half speed due to the homologous constitutional 
protein to the PrPSc only being present at 50% of the total level. The other 
constitutional protein, which is not homologous to PrPSc, making up the other 50%
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(Collinge and Palmer 1997). Evidence for this theory is provided by mice which 
are heterozygous for a PrP-null allele (and therefore only produce 50% of the 
normal levels of PrP), have a very prolonged incubation period and then develop a 
much more slowly progressive disease than wild type mice (Bueler et al. 1993,
1995).
• Ataxic CJD, occurring in about 10% of CJD cases, where individuals present with 
cerebellar ataxia rather than cognitive impairment (Gomori et a l 1973).
• In Heidenhain’s variant o f CJD cortical blindness is the dominant feature, with 
marked involvement of the cortical lobes.
• In the panencephalopathic type of CJD there is extensive degeneration of the 
cerebral white matter in addition to spongiform vacuolation o f the grey matter 
(Gomori et a l 1973).
• Amyotrophic forms of CJD with prominent early muscle wasting have been 
described but most cases are not experimentally transmissible (Salazer et a l 1983). 
These forms are not well understood and may be a late form of motor neurone 
disease.
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1.4 Relationship of PrP to the disease process
Recent extensive research into the PrP protein and the underlying infective agent has 
been undertaken, partially encouraged by the current BSE epidemic and the potential 
risk to man. The understanding of the PrP diseases has been greatly advanced, but a 
large controversy still exists as to the exact nature o f the infectious agent. The two 
main theories that exist are the prion hypothesis and the virion hypothesis. The prion 
hypothesis proposes that these diseases are caused by a proteinaceous particle devoid 
o f nucleic acid. The virion hypothesis proposes that an agent-specific replicable 
information molecule (either a nucleotide or polynucleotide) is bound to a protective 
host protein, PrP (Farquhar et al. 1998).
For the debate to be satisfactorily resolved either the production o f infectivity will 
have to be demonstrated through defined conformational changes of PrP, or an 
informational molecule with strain-specific properties will have to be demonstrated.
1.4.1 Virion hypothesis
The virion hypothesis was proposed due to the failure to explain how the PrP protein 
alone could specify the different TSE strain characteristics and how these 
characteristics could be strongly retained. The presence o f a small host-independent 
informational molecule encoding strain-specific characteristics does allow 
explanation o f the different TSE strain characteristics (Farquhar et al. 1998). Ionising 
irradiation studies have demonstrated a small target size for the infectious agent, 
which would be consistent with the size o f the nucleic acid genomes of small viruses 
(Rohwer, R.G. 1984). Extensive studies have so far demonstrated no evidence of a 
nucleic acid associated with the TSE’s and the virion hypothesis does not explain the 
transmissibility of PrPSc formed as a result o f a mutation of the PrP gene.
1.4.2 Prion hypothesis
As early as 1967 the idea o f a protein-only infectious particle was proposed (Griffiths 
1967), but it was only once Prusiner was able to co-purify prion protein with hamster 
scrapie infectivity that the infectious agent could be described as a proteinaceous 
infectious particle (Prusiner 1982). The term prion was introduced to distinguish 
these diseases from viral diseases, the term being derived from the nature o f the agent 
as a proteinaceous mfectious particle and a proposed working diagnosis described
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prions as ‘small proteinaceous infective particles which resist inactivation by 
processes that modify nucleic acids’ (Prusiner 1987). The prion, or protein-only, 
hypothesis suggests that replication occurs without the requirement o f informational 
input from DNA (Smith and Clarke 1997).
The main argument against the protein only hypothesis is the large number of prion 
strains that exist. The insoluble nature of the PrPSc has made analysis of its structure 
extremely difficult, but it does appear that information contained within the protein 
conformation of the PrPSc molecule may explain the strain variations that exist. That 
conformational information o f the PrPSc may be transferred to other PrP molecules, 
including PrP molecules o f a different primary structure, allows explanation o f strain 
stability and strain modification (Ridley and Baker 1997). Similar examples o f the 
transfer o f protein conformations have been demonstrated in the synthesis o f p53 and 
in experimental induction o f p-amyloid deposition in the brains o f middle aged 
monkeys on intracerebral injection o f p-amyloid containing brain tissue (Baker et al.
1994). In p53 synthesis, mutant p53 may drive the wildtype p53 to adopt the 
conformation of the mutant protein (Milner and Metcalf 1991).
1.4.3 Normal function and dynamics of PrP
PrPc (normal cellular isoform of prion protein) is highly conserved in mammals and 
may be present in all vertebrates, indicating that it probably has an important function. 
Certainly PrPc is found in high concentrations in neuronal membranes and lymphoid 
tissues (Jefferys 1997). The development o f at least two strains o f PrP-null mice has 
led to a further understanding o f the functions o f PrP. The most surprising factor 
being the absence o f severe clinical signs associated with the absence o f PrP. This 
has allowed certain theories about the exact function o f PrP to be discounted and 
demonstration that PrP plays a role in synaptic inhibition. Based on the absence of 
severe clinical signs associated with PrP-null mice, it has been proposed that PrP is 
strongly conserved not because it is essential to the well being of the organism, but 
rather that mutations of the PrP gene are associated with severe disease. Any 
deviations from the conserved sequence are therefore likely to be lethal (Ridley and 
Baker 1997).
PrP is rapidly synthesised and degraded, in contrast to the slow post-translational 
synthesis o f PrPSo. The initiation of PrP synthesis is in the endoplasmic reticulum 
(Caughey and Chesebro 1997) and from there the PrP transits through the Golgi
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apparatus. It is proposed that PrPc is transported in secretory vesicles to the cell 
surface, where the GPI anchor anchors it to the external surface. In contrast to this, 
although PrPSc is transported through the same excretory pathways, it accumulates in 
cytoplasmic vesicles within the cell, most o f the cytoplasmic vesicles being secondary 
lysosomes. From the external cell surface the PrPc is degraded inside the cell. It is 
thought that PrPSc formation takes place intracellular, the process being supplied by
n
PrP found briefly on the external surface of the cell (Prusiner 1997).
1.4.4 Proposed route of infection of PrPSc
Experimental studies have suggested that route o f spread o f PrPSc within the affected 
host is related to the route o f infection. The parenteral routes, especially where direct 
inoculation of the CNS occurs, are most efficient. In a field situation, infection 
through the gastrointestinal tract (GIT) is probably more significant. After 
introduction of the PrPSc into the stomach the first site of infectivity is the lymphoid 
system, including the tonsils, thymus, lymph nodes and spleen (Brown 1997; Klein et 
a l  1997). The widespread distribution o f target organs suggests that the agent 
spreads via the blood stream and this has been demonstrated experimentally (Brown
1997). Once infectivity is present in the peripheral lymphoid tissues then infectivity 
spreads to the CNS. The spread is though to be along peripheral nerves innervating 
these target tissues.
1.4.5 Proposed disease mechanism of PrPSc
The actual disease mechanisms in the TSE’s are still poorly understood. The disease 
related isoform of PrP, PrPSc, is thought to interact with, and cause a conformational 
change in, the post-translational PrPc, resulting in the conversion of PrPc to PrPSc. 
The pathogenic mechanism in the TSE’s is though to relate either to accumulation of 
PrPSc or depletion of functional PrPc. PrPSc is resistant to proteolysis and therefore 
accumulates in affected cells. Certainly in vitro experiments have shown that PrPSc 
accumulation is toxic to neurons, resulting in apoptosis, will result in astrocyte 
proliferation and may disturb the metabolism of some neurotransmitters (Caughey and 
Chesebro 1997). Development o f PrP-null mice has demonstrated only minor 
neurological abnormalities, with predominantly weakened synaptic inhibition, but no 
evidence o f the dramatic clinical signs of the TSE’s. This absence o f severe clinical 
signs has added weight to the argument that the pathogenic mechanism is due to
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accumulation o f the PrPSc (Jefferys 1997). It has been suggested, however, that the 
pathogenic mechanism may still be as a result o f loss of function of the PrP . This is 
as a result o f the rapid loss o f function in the disease state, while in the PrP-null mice 
the loss o f function is present over the lifetime of the animals, thus allowing adaptive 
changes to take place (Smith and Clarke 1997).
Although an extensive understanding o f the PrP has been developed over the 
preceding few years, o f which some brief points are raised here, a number of 
questions have still to be answered. The most perplexing o f these is the exact nature 
o f the infective agent.
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1.5 Spongiform changes in the CNS unrelated to prion diseases
A number o f situations exist where spongiform changes occur in the CNS, either as a 
normal feature or secondary to a variety o f non prion-related diseases. These need to 
be differentiated from the TSE’s. The majority o f these diseases are 
leukoencephalopathies and may be hereditary. Examples of these diseases will be 
discussed.
1.5.1 Vacuolation as a Normal Feature
Large cytoplasmic vacuoles may be seen as a normal feature in scattered neurons in 
the red nucleus o f cattle (Wells and McGill 1992). In 47 of 242 BSE negative bovine 
brains submitted under the BSE orders in Scotland, vacuolation o f the substantia nigra 
was present (Jeffrey 1992), and in the majority of these cases the cause o f the 
vacuolation was not determined. In sheep occasional vacuolated neurons are reported 
in the medulla (Zlotnick and Rennie 1958), while similar changes probably occur as a 
normal feature in pigs, cats (Wells and McGill 1992) and possibly other mammalian 
species. In older animals especially (but also younger foals) axonal spheroids and 
vacuoles may frequently be found in the lateral cuneate nucleus o f the medulla 
(Summers et al. 1995).
In the sympathetic ganglia of apparently normal horses and dogs it is not unusual to 
find large neuronal vacuoles which may occupy the majority o f the perikaryon and 
displace the nucleus (Brownlee 1959; Itakura 1960). In mature horses these large 
vacuoles may contain pale eosinophilic material. In humans an increased incidence of 
vacuolation o f autonomic neurons is seen in certain diseases o f the heart, blood 
vessels, intestines and larynx (Scharf 1958). Additionally, pseudovacuoles may be 
seen with retraction o f the neurons from their surrounding satellite cells.
1.5.2 White Matter Spongiform Degeneration
1.5.2.1 Spongy Degeneration o f the Bogaert-Bertrand Type (Canavan’s Disease)
This human disease is considered a classic example o f spongiform changes in a non- 
prion-related disease. It was first reported in 1949 by Bertrand and Bogaert 
(Adomato et a l  1972), and is characterised by a spongy degeneration affecting 
predominantly the white matter and grey matter margins of the brains o f affected 
children. Three patterns are recognised: congenital, infantile and juvenile forms.
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Gross lesions are evident in the brain at post mortem, with the brain being heavy, the 
lateral ventricles dilated and the white matter appearing grey and gelatinous. 
Histopathology reveals diffuse white matter vacuolation (described as status 
spongiosis) and pallor (Summers et al. 1995). The underlying hereditary defect 
results in elevated levels of N-acetylaspartic acid in the blood and urine, with 
depressed levels o f tissue aspartoacylase activity (Matalon et al 1988).
1.5.2.2 Hepatic Encephalopathy
In hepatic encephalopathy, and to a lesser extent in renal encephalopathy, 
neuropathological changes consist o f polymicrovacuolation (spongiform changes of 
the white matter) and Alzheimer type II cells (which are single or small groups of 
astrocytes with clear, swollen nuclei). A large disparity exists between the severity of 
clinical signs and the degree of neuropathological changes in the brain.
The polymicrovacuolation associated with hepatic encephalopathy occurs diffusely 
through the neuroaxis, particularly affecting the white matter (and especially where 
myelinated fibres are interspersed with grey matter). Particular regions affected 
include the peripheral corona radiata, internal capsule, thalamus, hypothalamus, 
cerebellar white matter and peduncles, pons, medulla oblongata and the fasciculus 
proprius o f the spinal cord. The bilaterally symmetrical nature o f the changes is 
consistent with a metabolic disease (Summers et al. 1995).
1.5.2.3 Toxicity Associated with Spongy Degeneration of the CNS
1.5.2.3.1 Lupinosis in sheep
Vacuolation o f the white matter o f the brain stem, in the absence o f other changes in 
the CNS, has been reported in acute and chronic experimental lupinosis and chronic, 
naturally occurring lupinosis in sheep. The degree and extent o f the CNS vacuolation 
reported was related to the severity o f the primary liver lesion (Allen and Nottle 
1979).
1.5.2.3.2 Hexachlorophene
A diffuse spongy degeneration affecting the entire CNS has been reported in cats due 
to accidental ingestion of, or medical use of, hexachlorophene, which has been 
incorporated into soaps and other products (O’Brien 1996). Other toxins that have
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induced a spongy degeneration include triethyltin, isoniazid, Cuprizone and 
bromethalin (O ’Brien 1996).
1.5.2.4 Other causes o f  white matter spongiform degeneration
Numerous other causes o f spongiform degeneration o f the white matter have been 
described. Some o f those of significance in light o f the recent BSE epidemic and the 
associated research include: spongy degeneration in British white cattle (O’Brien
1996), maple syrup urine disease o f Hereford cattle (Cordy et a l  1969), cerebral 
oedema of Hereford cattle, spongy degeneration in outbred Swiss-Webster mice, 
spongy degeneration of rats and hereditary ataxia of rabbits.
1.5.3 Grey Matter Spongiform Degeneration
1.5.3.1 Ischaemic Injury
Fine neuronal vacuolation, due to swelling of the endoplasmic reticulum or 
mitochondria, may be found as a result o f an ischaemic incident (Summers et al.
1995).
1.5.3.2 Bull M a stiff puppies
A disorder has been described in bullmastiff puppies characterised by neurological 
abnormalities, including ataxia, proprioceptive deficits, hypermetria, visual deficits 
and bizarre behaviour. Bilaterally symmetrical vacuolation and gliosis, most marked 
in the cerebellar nuclei, is apparent on neuropathological examination (Carmichael et 
a l  1983).
1.5.3.3 Saluki puppies
A similar disorder to that in bullmastiff puppies has been described in saluki puppies. 
The disease is characterised by the presence of a pronounced spongiosis with 
associated swollen astrocytes in the grey matter of nuclei like the olivery nuclei and 
cerebellar nuclei (Luttgen and Storts 1987).
1.5.3.4 Malinois Shepherd-cross puppies
A disorder has been described in two malinois shepherd-cross puppies associated with 
progressive and generalised tremors. Pathological examination revealed a widespread 
spongiosis with associated astrocytosis of the CNS, particularly affecting the grey
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matter. The changes were present in the cerebral cortex, basal nuclei, brain stem, 
cerebellar nuclei and grey matter o f the cervical and lumbar enlargements (Cachin and 
Vandevelde 1991).
1.5.3.5 Birman Kittens
A progressive disorder characterised by paraparesis and ataxia has been described in 
young Birman kittens. Pathological examination revealed spongiform changes 
affecting the neuropil o f the cerebral cortex, thalamus, caudal colliculi, oculomotor 
nuclei and the medulla (Jones et a l  1992).
1.5.3.6 Lysosomal Storage Diseases
The accumulation o f cytosomes due to an inherited or acquired lysosomal enzyme 
defect results in cell swelling and a granular to vacuolar appearance o f the cytoplasm 
(Summers et al. 1995).
1.5.3.7 Rabies
Vacuolar changes in the neuropil and neuronal cell bodies have been described in 
experimental and naturally acquired rabies in skunks, foxes and a heifer (Foley and 
Zachary 1995). In the heifer the spongiform changes affected the neuropil and 
neuronal cell bodies of especially the thalamus and cerebral cortex. Although no 
Negri bodies were found in any o f the sections the brain was positive for rabies virus 
antigen using fluorescent antibody testing.
1.5.3.8 Neuronal Vacuolation and Spinocerebellar Degeneration in Young 
Rottweiler Dogs
Three recent reports (Kortz et al. 1997; Andrade-Neto et al 1998; van den Ingh et al
1998) have documented a progressive disorder in rottweiler puppies characterised by 
tetraparesis, ataxia and proprioceptive deficits. A prominent feature o f the 
histopathological examination was vacuolation o f the neuronal cytoplasm, particularly 
in the cerebellar nuclei and nuclei o f the extrapyramidal system. Similar vacuolation 
was reported in the spinal ganglia (dorsal root ganglia) and the autonomic ganglia.
1.5.3.9 Neuronal Vacuolation in Racoons
A recent report (Hamir et al. 1997) has documented neuronal vacuolation in two 
apparently clinically normal racoons in the United States (from different geographical
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locations). The vacuolar changes in the first racoon were limited to the brain stem, 
with bilateral, asymmetrical vacuoles (single or multiple) in the neurons o f the facial 
nucleus. In the second case, the changes were similar, but more widespread in the 
brain stem and cerebrum, but not in the cerebellum. In both cases no inflammatory 
infiltrate was associated with the vacuolar changes and in both cases the animals were 
negative for rabies and scrapie associated fibrils.
1.5.3.10 Vacuolation o f grey matter neuropil in laboratory animals
In light of the rodent models used to study the prion diseases, other causes of grey 
matter neuropil vacuolation in these species are potentially significant. Examples 
include a retroviral infection in mice, the grey tremor mutant mouse (Kinney and 
Sidman 1986) and the zitter rat (Gomi et al. 1990).
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1.6 Aims of this thesis
The major aims of the present study are threefold.
1. To present a review o f the current literature on feline spongiform encephalopathy. 
A brief resume of the relevant current literature on other transmissible spongiform 
encephalopathies is included and their relationship to feline spongiform 
encephalopathy (where appropriate) is discussed.
2. To present the clinical features o f pathologically confirmed cases of FSE, as seen at 
the University o f Glasgow Veterinary School, and to compare these with the 
published data. The clinical criteria for the presumptive antemortem diagnosis of 
feline spongiform encephalopathy are considered. Furthermore, a limited 
epidemiological study is presented, where appropriate details are available from the 
cases included in this project.
3. To present a detailed study of the pathology o f feline spongiform encephalopathy 
in the cases included in this study. The distribution and nature o f changes in the brain 
and spinal cord are investigated, using classical methods and immunocytochemical 
techniques. This latter aspect includes an investigation into both the appearance and 
pattern of distribution o f the disease-related isoform of PrP deposition. An attempt is 
made to correlate the clinical presentation with the observed pathological changes.
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Materials and methods
2.1 Collection of clinical material
2.1.1 Case selection
All cases o f histopathologically confirmed cases of FSE seen at the Faculty of 
Veterinary Medicine, University o f Glasgow, were included in this study, up to and 
including May 1998. Two of the cases were presented for post mortem examination 
after investigation at the referring veterinary surgeon, while the other seven cases 
were presented to the Department of Veterinary Clinical Studies for investigation of 
an apparent neurological abnormality. Details o f the cases are presented in chapter 3.
In the cases presented to the Department o f Veterinary Clinical Studies for 
investigation a detailed history was obtained and a full clinical and neurological 
examination was performed, although details in the earlier cases were not as complete 
as in later cases. In one of the two cases presented for post mortem examination a 
detailed history had been taken and a full clinical and neurological examination had 
been performed by the referring veterinary surgeon, while in the second case only 
limited information was available.
2.1.2 Investigation of cases
The signalment was obtained for all cases. Full histories were obtained, where 
possible, by a retrospective review of the clinical records and hospital database or, in 
the three cats presented during the course of the study, by detailed questioning of the 
owners.
A full clinical and neurological examination was performed as detailed by Oliver, 
Lorenz and Komegay (1997), including a partial ophthalmologic examination. 
Further details o f the functional tests that were found to be the most useful are 
presented in chapter 3.
2.1.3 Ancillary investigations
Further diagnostic procedures were performed in the majority of cases in order to rule 
out other potential causes o f the clinical signs. The relevant tests are detailed in the 
clinical appraisal chapter.
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Routine haematological evaluation was performed in five cases and routine 
biochemical evaluation was performed in six cases. These evaluations were 
performed to rule out the possibility of systemic disease and as a pre-anaesthetic 
evaluation o f general health. Red blood cell counts, haematocrit, haemoglobin 
concentration, mean corpuscular volume, mean cell haemoglobin, platelet count and 
total and differential white blood cell counts were determined. Plasma concentrations 
o f urea, creatinine, sodium, potassium, chloride, calcium, phosphate, glucose, 
cholesterol, bilirubin, alkaline phosphatase, alanine transferase (ALT), aspartate 
transferase (AST), creatinine kinase, total protein, albumin and globulin were 
analysed. Results of these tests were compared to reference ranges of GUVS 
laboratories.
Blood samples were submitted to the Feline Virus Unit at GUVS for determination of 
antibodies to feline leukaemia virus (FeLV) in five cases, feline immunodeficiency 
virus (FIV) in four cases and feline coronavirus (FIP) in four cases. Furthermore the 
antibody titre to toxoplasmosis was determined using a dye test in three cases.
Thyroid function was evaluated in two cases by determining the plasma thyroxine 
levels. A bone marrow aspirate was performed in one case. The technique used is 
described by O ’Keefe (1992).
In two cases CSF samples were obtained, in one case from the cerebellomedullary 
cistern and in the other case from the lumbar cistern. The collection site was clipped 
and aseptically prepared. The cerebellomedullary cistern sample was collected using 
a 22 gauge, one-inch hypodermic needle. The technique used is described by Rand 
(1995). The lumbar cistern sample was collected via the interarcuate space between 
the sixth and seventh lumbar vertebrae, as described by Wheeler et al (1985). A one 
and a half inch, 22 gauge spinal needle (Monoject Spinal Needle, Sherwood Medical 
Industries, St. Louis, USA) was used.
The samples were inspected for colour, consistency and turbidity. The cell counts and 
total protein concentrations were determined and compared to reference values given 
by Bailey and Higgins (1985).
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2.1.4 Collection of control material
Brains were collected from ten control cases, six of which had no abnormalities in the 
CNS and four of which had non-prion-related disease o f the CNS. The spinal cord 
was collected from six of the control cases, five of which had no abnormalities in the 
CNS and one with an intracranial astrocytoma. Fixation and processing of the control 
cases was identical to the affected cases, with the exception that the control material 
for haematoxylin and eosin (H&E) staining and GFAP immunocytochemistry was not 
immersed in formic acid prior to processing. The control material for PrP 
immunocytochemistry was pre-treated with formic acid in a similar was to the 
material from the affected cases. Details of the signalment, clinical details and 
available tissue from the control cases are summarised in Table 4. In all the control 
cases the brain was sectioned in a standard manner, with the positioning of the 
sections as described in Fraser and Dickinson (1968).
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Signalment Diagnosis Tissue
9.5 year old 
neutered female 
domestic short hair
meningioma, over left ventral 
brain stem and piriform lobe
brain
8 year old neutered 
male domestic short 
hair
astrocytoma o f 4th and 5th 
cervical spinal cord segments
brain
12 year old male 
neutered domestic 
short hair
chronic renal failure, 
polyneuropathy and cerebral 
meningioma
brain
6 year old female 
neutered domestic 
short hair
iliac saddle thrombus brain
1 year old domestic 
short hair
normal brain; spinal cord segments 
C3, C7 and T3; spinal ganglia
1 year old domestic 
short hair
normal brain; spinal cord segments 
C3, C7 and T2; spinal ganglia
1 year old domestic 
short hair
normal brain; spinal cord segments 
C2, C6 and T3; spinal ganglia
1 year old domestic 
short hair
normal brain; spinal cord segments 
C2, C6 and T2; spinal ganglia
1 year old domestic 
short hair
normal brain; spinal cord segments 
C2, C6 and T4; spinal ganglia
5 year old female 
neutered domestic 
long hair cat
intracranial astrocytoma brain; spinal cord segments 
from cervical and lumbar 
enlargements and the thoracic 
region; spinal ganglia
Table 4 Control cases: signalment, clinical details and tissues processed
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2.2 Tissue collection and fixation
2.2.1 Post-mortem examination
Due to the risk to personnel, in any suspected FSE case the post-mortem was 
performed according to guidelines. Personnel involved in the examination were kept 
to a minimum and all personnel involved were required to wear protective gowns and 
gloves. The person responsible for removing the brain and spinal cord additionally 
wore a protective face visor. Access to the post-mortem area was limited for the 
duration of the post-mortem examination. All work surfaces were covered with 
disposable drapes. On completion o f the post-mortem all the protective gowns, 
drapes and gloves were incinerated. Where possible, disposable instruments were 
used and these were disposed o f by incineration. The carcass was also incinerated. 
Remaining, non-disposable instruments and table surfaces were decontaminated by 
exposure to sodium hypochlorite (Presept) and the instruments kept separate from the 
other instruments in the post-mortem room.
2.2.2 Buffered neutral formaldehyde, 4% (BNF)
This fixative was used for tissues destined for routine H&E staining and 
immunocytochemistry (see appendix for details). The brain was removed entire and 
immersion-fixed for at least a week prior to sectioning. The spinal cord was removed 
with the surrounding meningeal layers intact and was suspended in a BNF-filled 
cylinder, with the end weighted to keep it straight and prevent artefact. A 
representative sample o f the lymphoid tissues, including spleen, peripheral, colonic 
and bronchial lymph nodes and tonsil, was removed from three o f the cases and 
immersion fixed in 4% BNF.
2.3 Tissue processing
2.3.1 Paraffin processing
Prior to processing, the blocks from the clinical cases were immersed in neat formic 
acid (96%) for 30 minutes to decrease the infectivity of the tissues and therefore 
decrease the risk to personnel. The control material for H&E staining and GFAP 
immunocytochemistry was not immersed in formic acid, although the sections for PrP 
immunocytochemistry were. It was not thought that this difference in tissue 
processing would significantly affect the H&E staining or the GFAP
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immunocytochemistry. The 24-hour paraffin wax processing cycle was used for 
blocks from the spinal cord and smaller brain blocks perfused with BNF. The seven 
day paraffin wax processing cycle was used for larger brain blocks perfused with 
BNF. The blocks of neural tissue were placed in processing cassettes and loaded in 
the basket of a Shandon Elliot automatic processor (Histokinette). The tissues were 
then passed through dehydrating solutions and infiltrated with wax (see Appendix for 
details of the solutions) before being embedded in paraffin wax at 60°C.
2.3.2 Sections
The paraffin-embedded tissue sections were sectioned on a Biocut 2035 microtome 
(Leica) at 8pm. The sections were mounted on APES-coated slides and incubated 
overnight at 60°C.
2.4 Staining Techniques
2.4.1 Haematoxylin and Eosin
Paraffin sections were stained with H&E to assess tissue morphology and 
preservation (see Appendix for details o f the staining method). Once stained the 
sections were mounted in DPX (BDH).
2.4.2 Haematoxylin
Sections for GFAP and PrP immunostaining were counterstained with haematoxylin 
to demonstrate nuclear detail (see Appendix for details o f the staining method).
2.5 immunocytochemistry
2.5.1 GFAP immunocytochemistry
Representative sections from the affected and control cases were processed for GFAP 
immunocytochemistry. The rabbit anti-GFAP antibody was used at a dilution of 
1:3000 (DAKO), with a goat anti-rabbit link antibody (1:10, Sigma) and a rabbit 
(1:40) peroxidase anti-peroxidase (PAP) complex (ICN).
The paraffin wax-embedded sections were hydrated in:
1. xylene 2m in.
2. absolute alcohol 2 min.
3. methylated spirit 2 min.
57
Materials and methods
4. water
5. Lugol’s iodine
6. water
2 min.
1 min.
1 min.
7. 5% sodium thiosulphate (hypo) 1 min.
8. water
Endogenous peroxidase activity was quenched by immersing the slides in 3% 
hydrogen peroxidase (in absolute alcohol) for 30 minutes, followed by a wash in 
running water for 30 minutes. Incubating in 10% normal goat serum (NGS) in PBS 
for 2 hours at room temperature blocked non-specific binding. Sections were 
incubated in the rabbit anti-GFAP antibody in 1% NGS in PBS overnight at 4°C. 
Sections were adjusted to room temperature and washed for 30 minutes in PBS (6 
changes), followed by the goat anti-rabbit link antibody in 1% NGS at room 
temperature for 1 hour. Excess antibody was removed by washing in PBS for 30 
minutes (6 changes) and the sections incubated in the PAP complex for 30 minutes at 
room temperature. Excess was removed by washing in PBS for 30 minutes (6 
changes). The chromogen was developed in filtered 0.1M phosphate buffer (pH 7.3) 
containing 0.5mg/ml 3,4,4',4',-tetraminobiphenyl hydrochloride (DAB) and 0.003% 
hydrogen peroxide until the required colour intensity had been achieved (30 sec. to 5 
min.). Sections were washed in running water, dehydrated and mounted in DPX 
(BDH).
2.5.2 PrP immunocytochemistry
Representative sections from the affected and control cases were processed for PrP 
immunocytochemistry. The monoclonal PrP antibody 3F4 was used and the pre­
treatment of the sections included incubation in 96% formic acid for five minutes, 
then incubation in 4M of guanidine thiocyanate for two hours and then hydrated 
autoclaving at 121°C for 10 minutes.
The PrP immunocytochemistry was performed at the National Creutzfeldt-Jakob 
Disease Surveillance Unit in Edinburgh and details o f the methodology have been 
published (Bell et al 1997; Goodbrand et al 1995).
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2.6 Morphometry
2.6.1 Histopathological assessment
Sections from the spinal cord and brain from the affected cases were assessed for the 
presence o f vacuolar changes, both intraneuronal and in the surrounding neuropil. 
The presence of neuronal loss was determined, by comparison to control cases, and 
the degree of glial reaction was assessed.
2.6.2 Vacuolar score
Sections from the brains o f affected cases, in which the level o f the section correlated 
to standard levels described by Fraser and Dickinson (1968) were assessed for the 
degree o f vacuolation in nine defined areas. The limits o f these nine areas were 
defined by Fraser and Dickinson (1968). The degree o f vacuolation in these defined 
areas was ascribed a subjective numeric score ranging from zero to five, according to 
the degree of vacuolation grossly visible (Fraser and Dickinson 1968).
The numeric score was converted to a graphically depicted lesion profile (Fraser and 
Dickinson 1973), which allows comparison with the lesion profiles published for 
TSE’s in other species, including that described in bovine spongiform encephalopathy 
(Wells e ta l  1992)
2.6.3 Astrocytic response
Assessment of the astrocytic response was performed by comparison of glial numbers 
and appearance o f affected cases and control cases on H&E sections. The distribution 
and intensity o f GFAP immunocytochemistry o f affected and control cases was 
compared. In both methods the comparison was purely subjective and no attempt at 
exact quantification was made.
2.6.4 PrP distribution
The appearance and distribution o f the PrPSc deposition, by means o f PrP 
immunocytochemistry, was compared in affected cases and control cases. This was 
performed at all brain and spinal cord levels available.
59
Materials and methods
2.7 Image recording
Photographs of histological sections were taken on an Olympus Vanox-S. Suitable 
images were scanned from transparencies using a Coolscan II (Nikon) and the images 
printed on an Epson Stylus Color 800.
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3.1 Introduction
The clinical signs and epidemiology associated with FSE have been reported. These 
descriptions have been limited to a single large series of cases (Pearson et al. 1993), 
supplemented by a number o f individual case reports (Bratberg et al. 1995; Leggett et 
al. 1990; Synge and Waters 1991). Details of the published clinical presentation of 
FSE are summarised in chapter 1. The present study allows comparison with the 
single published large series o f cases (Pearson et al. 1993) and contributes to the 
limited published database available on FSE.
3.2 Aims
One major aim of the present study was to present the clinical appearance of 
pathologically-confirmed cases o f FSE seen at Glasgow Veterinary School and 
compare these to the published findings, thereby improving the clinical knowledge of 
FSE. Attempting to define clinical criteria for presumptive ante-mortal diagnosis of 
FSE was of particular interest. A limited epidemiological discussion is presented on 
cases where appropriate details are available.
3.3 Materials and Methods
3.3.1 Selection of cases
The cases were sourced from a wide distribution over northern England and Scotland, 
details of the geographic distribution are presented in the discussion on the 
epidemiology. Two of the cases were presented to the Glasgow University Veterinary 
School for post mortem examination after telephonic discussion with the referring 
veterinary surgeon. The other seven cases were presented to the Department of 
Clinical Studies for investigation. Only cases where the diagnosis of FSE was 
confirmed on post mortem examination are included in this study. Details o f the 
cases included in this study are presented in Table 5.
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Case
number
Age at 
euthanasia
Breed Sex
1 XN1241 9 years Domestic Short Hair Male Neutered
2 114446 8 years Domestic Short Hair Female Neutered
3 117393 6 years Domestic Short Hair Female Neutered
4 118260 9 years Domestic Short Hair Male Neutered
5 123398 5 years Domestic Short Hair Female Neutered
6 126399 7 years Siamese Blue-point Female Neutered
7 129453 3 years Domestic Short Hair Female Neutered
8 131333 9.4 years Domestic Short Hair Female
9 134380 6 years Domestic Short Hair Male Neutered
Table 5 Clinical details of the FSE cases (domestic cats) included in this study.
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3.3.2 Investigation of cases
The signalment was obtained for all cases. Full histories were obtained, where 
possible, by a retrospective review of the clinical records and hospital database or, in 
the four cases presented during the course o f the study, by detailed questioning of the 
owners. Recorded details in some of the retrospectively identified cases were 
incomplete.
A full clinical and neurological examination was performed as detailed by Oliver et al 
(1997) (for details see chapter 2), including a fundic examination. The following 
functional tests were found to be the most useful in the FSE cases:
• Allowing the cat to walk unimpeded around a consulting room, having first given 
the cat chance to become accustomed to the room. The cat’s posture was evaluated 
while the cat was walking around the room and by getting it to stand still on the 
examination table.
• The cat’s interaction with the environment was assessed, as was the cat’s level of 
consciousness and response to visual, auditory and tactile stimuli.
• Weakness was evaluated by hopping and wheelbarrow, hemi-stand, hemi-walk and 
extensor postural thrust testing. Due to the timidity and/or aggression displayed as 
part o f the clinical presentation these tests were either performed only partially or 
impossible to perform in a number of the cases.
• Proprioception, or the animal’s awareness of the position o f its limbs in space, was 
evaluated by paw position testing and further sensory function was studied by 
tactile placing and visual placing tests. Again this was not possible in all cases due 
to the aggression and/or timidity which was a feature of FSE.
• The spinal reflexes evaluated included, in the hind limbs: the patellar reflex, pedal 
reflex and assessment of muscle tone; in the forelimbs: the extensor carpi radialis 
reflex, pedal reflex and muscle tone; and along the thoraco-lumbar spine the 
panniculus reflex. All limbs were assessed for the presence o f muscle atrophy.
• A full cranial nerve examination was performed, including assessing the 
sympathetic supply to the cranial region.
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In one o f the two cases presented for post mortem examination a detailed history and 
full clinical and neurological examination were available from the referring veterinary 
surgeon, while in the second case only limited information was available.
A variety o f laboratory investigations were performed, including complete blood 
count, biochemistry, virus and toxoplasmosis status determination, cerebrospinal fluid 
(CSF) analysis, bone marrow aspirates and serum thyroxine determinations. The 
results were compared to the normal laboratory values.
3.3.3 Therapies
The TSE’s are progressive and invariably fatal neurodegenerative disorders for which 
there are no recognised therapies. Due to the absence o f a definitive ante-mortem test 
to confirm the presence o f FSE, a number of cases in this series where tried on a 
variety o f drugs, as treatment for other potential differential diagnoses. Details o f the 
therapies administered in the various cases are presented in Table 6.
3.3.4 Epidemiology
Due to the strong circumstantial evidence linking the outbreak o f FSE to 
contamination o f cat feed with BSE material, detailed dietary information was 
obtained from each of the affected cases to assess if  any risk factor could be 
identified. Available dietary information o f the cases is presented in Table 9. The 
geographic distribution o f the cases was examined, to determine if  any regional 
differences could be identified, taking into account the normal area serviced by the 
veterinary school.
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Case Therapies
1 XN1241 Details not available
2 114446 Treatment# on day 1, 3 and 7 with:
• Betamethasone injectable (Betsolan, Mallinckrodt Veterinary)
• Vitamin B 12 injectable (Anivit Bi2250, Animalcare)
• Amoxycillin injectable (Amoxypen LA, Intervet)
3 117393 Details not available
4 118260 Treatment# on day 1 and 2 with: antibiotic injection 
Treatment# on day 4 and 7 with: antibiotic and steroid injections
5 123398 Details not available
6 126399 Treatment# on separate dates with:
• Steroid injection and diazepam tablets (Valium)
• Potentiated sulphonamide injectable (Zaquilan 20%, 
Mallinckrodt Veterinary) and antibiotic tablets
7 129453 Treatmentn with:
• Canaural ear drops and antibiotic tablets
8 131333
jj
Treatment with:
• Dexamethasone injectable (Voren 14, Boehringer Ingleheim)
• Prednisolone 5mg tablets (Prednicare): one tablet daily for five 
days
Treatment with:
• Prednisolone 5mg tablets (Prednicare)
9 134380 Treatment# with:
• Clavulanate potentiated amoxycillin tablets (Synulox 50mg 
tablets, Pfizer)
• Steroid and Ovarid tablets
Table 6 Details of therapies administered (day numbers are days from the start of 
treatment; the sym bol# implies that the treatment was given at the referring veterinary 
surgery, available details are provided).
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3.4 Results
3.4.1 Number of cases in the study
Nine cases o f FSE were identified in domestic cats in this series. Details of the cases 
are presented in Table 5. Five cases were female neutered, one was an entire female 
and the remaining three cases were male neutered. Eight o f the cases were domestic 
short hair cats and the remaining case a blue-point Siamese.
3.4.2 History
All of the cases presented with a combination o f behavioural changes and ataxia. In 
all cases the onset o f the behavioural changes preceded or coincided with the onset of 
the ataxia.
The altered behaviour and ataxia were progressive in all o f the cases and varied in 
onset from 2 weeks to nine months prior to presentation. Not all o f the behavioural 
changes were evident in all cases, and various combinations were present. Only 
limited details were available in some of the cases.
The behavioural changes reported by the owners are summarised in Table 7. All of 
the cases were characterised by the presence o f hyperaesthesia. The hyperaesthesia 
was present in response to auditory stimuli in all cases, but in a number of cases it was 
additionally noticed in response to tactile and visual stimuli.
In one case the owners reported that the cat had started urinating and defecating 
inappropriately in the house. In another two cases, the owners remarked that the cats 
had altered their toilet habits. In one case the cat started using its litter tray where it 
had never used it before (this case also developed extreme reluctance to go outside) 
and a further case had difficulty using the litter tray because of the moderate ataxia 
which had developed by that stage.
The altered behaviour in six of the cases was characterised by marked timidity, with 
the cats hiding under furniture and appearing apprehensive if  people approached. 
Three of these cases demonstrating timidity also displayed aggression, one towards 
other cats in the house and one towards strangers. Five of the cats displaying timidity 
appeared reluctant to venture outside or into open spaces and in some of the cases the 
owners remarked that cats which had previously appeared outgoing and independent 
did not now leave the house voluntarily.
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Two cats were reported to be sleeping in unusual places and not where they usually 
slept. One of these cases started sleeping on the banister of the stairs, while the other 
case started sleeping on the back of chairs. In both cases, due to the development of 
the ataxia, the owners remarked that they would frequently fall off.
In two cases the owners remarked that the cats were not interacting normally with the 
other cats in the household, manifesting either as the affected cat ignoring normal cats 
in the household, or vice-versa.
Decreased grooming was a feature of three cases, although in one o f these cases the 
owners ascribed this to the marked ataxia and therefore a physical inability to both 
maintain its balance and groom. In only one case was there evidence o f pruritis, 
which was based on the presence of a positive nibble reaction when the cat was 
scratched. A noticeable feature in five o f the cases was the presence of 
hypersalivation.
One case appeared dull and depressed according to the owners. In one case the cat 
had difficulty eating, which was ascribed to the presence of the ataxia and intention 
tremor.
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Altered toilet habits
Dull I Depressed
Decreased grooming
Difficulty eating
Pruritis
Loss of housetraining
Stopped going outside
Hypersaiivation
Altered cat socialisation
Sleeping in strange 
places
Hyperaesthesia
Increased aggression
Increased timidity
0 1 2 3 4 5 6 7 8 9
Table 7 Reported altered behaviour, and relative frequency at which they occurred 
(due to limited records some aspects may be under-reported).
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3.4.3 Physical examination
Apart from the abnormalities discussed under the history (including hypersalivation, 
saliva staining o f the face and decreased grooming) the only significant abnormalities 
detected on the physical examination are discussed under the neurological 
examination (including ataxia and intermittent pupillary dilation).
In three cases, routine ophthalmologic examination (including a fundic examination) 
did not reveal any abnormalities. No details are available as to whether the remaining 
cases had an ophthalmologic examination.
3.4.4 Neurological examination
The neurological findings were characterised by a multifocal lesion distribution, 
dominated by a cerebellar-based ataxia and tremor. Serial neurological examinations 
demonstrated a progression o f signs. The findings of the neurological examination 
are summarised in Table 8.
Ataxia was present in all cases and in 6 of the 9 cases the hind limbs appeared more 
severely affected than the forelimbs. In two cases there were only limited details 
available o f the neurological examination. Many of the other features may, therefore, 
be under-represented.
A tremor was frequently present and included mild involvement o f the head and tail at 
rest and the presence o f an intention tremor. In addition a marked truncal sway was 
frequently present, becoming more noticeable with effort. Hypermetria was evident 
in three cases, a wide based stance in three cases, a crouched posture in three cases 
and an inability to jump up or down onto surfaces in four cases.
The falling and circling to the left in one case was interpreted as vestibular disease 
(due either to damage to the vestibular nuclei or nerve, or to loss o f inhibition of the 
right vestibular nuclei).
As evidence o f either brain stem or cerebral involvement, four cases had mild sensory 
deficits, including conscious proprioceptive deficits (CPD’s), in the hind limbs.
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A feature of the clinical picture in 6 of the 7 cases where details of a complete 
neurological examination were available, was an intermittent pupillary dilation, in the 
presence of normal pupillary light reflexes.
3.4.5 Further investigations
CSF analysis was successfully performed in two cases. In one cat the protein level, 
on a lumbar puncture, was elevated at 1150mg/l (normal <450mg/l), while it was 
within normal limits in the other case. The CSF cell count was within normal limits 
in both cases.
In the five cases where serology was performed for FeLV, and the four cases where 
serology was performed for FIV, there was a negative result. In the four cases where 
an FIP titre was performed, the titre was zero. The Toxoplasmosis titre was 
determined by means o f a dye test in three cases, in two cats it was considered 
negative, while in a third cat the titre was elevated at 30 IU/1.
Routine biochemistry was performed in six cases, and in five cases routine 
haematology was performed. Although occasional anomalies were present, no 
consistently abnormal values were identified affecting a majority of the cases. The 
bone marrow aspirate performed in one case did not reveal any abnormalities. The 
thyroxine determination performed in two cases was within normal limits.
3.4.6 Therapies
In none of the cases where treatment was attempted was there any documented 
improvement on assessment by the owner, the referring veterinary or myself. 
Progression of the clinical signs was evident in cases eight, nine and ten, during the 
period o f treatment. Details of the therapies attempted are presented in Table 6.
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Vestibular disease
Truncal sway
Hypermetria
Wide based stance
CPD's
Pupillary dilation
Crouched posture
Tremor at rest
Inability to jump up
Intention tremor
Ataxia
“ I--------------------- 1--------------------- 1--------------------- 1--------------------- 1--------------------- 1--------------------- 1--------------------- T
10
Table 8 Findings on neurological examination, excluding features in Table 7.
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3.4.7 Epidemiology
3.4. 7.1 Dietary information
In the majority o f the cases the diet consisted o f commercially available tinned cat 
food. A variety o f the widely available brand types were represented. In addition a 
number o f cases were fed additional table scraps and milk, although in all cases these 
additional components did not constitute the majority of the diet. Two cases were 
never given milk as a part o f the diet, in an additional case the cat was given milk 
only when a kitten and not subsequently. The available dietary information is 
presented in Table 9.
3.4. 7.2 Geographic distribution
Details of the geographic origin of eight o f the cases are available. The majority (6 
cases) originated from the region o f Scotland immediately serviced by Glasgow 
Veterinary School (including Prestwick, Hamilton, Ayr, Uddingston, Lanark and 
Larkhall), while two o f the cases originate from the midlands and north England 
(Leicester and Leeds).
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Case Diet
1 XN1241 Not available
2 114446 Tinned commercial cat food 
Occasional dry cat food, tuna and chicken 
Never given milk
3 117393 Not available
4 118260 Tinned commercial cat food (predominantly fish flavoured) 
Occasional dry cat food, cheese, meat and table scraps 
Never given milk
5 123398 Not available
6 126399 Tinned commercial cat food 
Occasional milk and table scraps
7 129453 Tinned commercial cat food
8 131333 Tinned commercial cat food
9 134380 Tinned commercial cat food
Very occasional ham and cheese to give pills
Milk as kitten, but not subsequently
Table 9 Available dietary information.
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3.5 Discussion
Although the number o f cases in this series is limited to nine, the total number of 
pathologically confirmed cases of FSE to the 1st of January 1998 numbered only 84 
worldwide, with 81 of those occurring in the UK. In relation to the total number of 
confirmed and the limited number of published cases of FSE (Bratberg et al. 1995; 
Leggett et a l 1990; Pearson et al. 1993; Synge and Waters 1991), a number of 
aspects, based on the clinical material presented in this study, are apparent.
The history and neurological findings in this series correlates well with published 
clinical details for FSE. The onset of the behavioural changes precedes or coincides 
with the onset of the ataxia, which is in contrast to that reported by Gruffydd-Jones 
(1997), but correlates with that reported by Pearson et al. (1993).
Some of the aspects evident from the history, signalment and clinical investigations 
include:
1. No evidence of a sex or breed predilection could be identified, in contrast to the 
male predominance in a previous series of FSE cases (Pearson et al. 1993).
2. No identifiable geographic clustering of cases could be demonstrated.
3. Routine clinical investigation (besides the findings apparent on the history and the 
neurological examination), including blood tests and serology, did not identify any 
clinical criteria that would support a diagnosis of FSE.
4. CSF analysis did not appear useful in identifying any criteria supporting the 
diagnosis of FSE. CSF analysis may, however, be o f use to rule out other 
differential diagnoses, but an abnormal CSF analysis does not necessarily preclude 
a potential diagnosis of FSE. Addition consideration should be given to the 
potential zoonotic risk, when performing the collection and analysis of CSF in 
suspected cases.
5. No demonstrable improvement was apparent in any o f the cases where treatment 
was attempted. In the absence o f a specific ante-mortem test for FSE, a treatment 
regime designed to rule out other potential causes of the clinical signs would be 
justified.
6. Circumstantial evidence suggests that the origin of FSE is related to contamination 
of cat feed with BSE infected material (Bruce et al. 1997, Collinge et al. 1996). In
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the seven cases in this series where detailed dietary information was available, the 
predominant dietary component was commercially available tinned cat food.
Based on the clinical features o f the cases in this series, a set of clinical criteria were 
identified which, if  they are present in a case, would allow a presumptive ante- 
mortem diagnosis of FSE.
1. All cases presented with progressive behavioural changes (details o f which, and 
the frequency at which they occurred, are presented in Table 7) which preceded, or 
coincided with, the development o f progressive ataxia.
2. Hyperaesthesia, either to auditory, tactile or visual stimuli was present in all cases.
3. Ataxia was present in all cases. The nature o f the ataxia suggested a 
predominantly cerebellar location.
4. Hypersalivation was evident in five o f the cases. Limited clinical details in some 
of the earlier cases and the fact that this feature was identified as being related to 
FSE only after a number of cases had already been described, suggests that this 
feature may have been underreported in the earlier cases and may therefore occur 
at a higher frequency.
5. Intermittent pupillary dilation with intact photo-motor reflexes was evident in six 
of the cases but for the same reasons as listed in point 4 may have been 
underreported.
The clinical presentation allows some prediction as to the site o f the pathology that 
would be expected. The history and findings on the neurological examination are 
suggestive o f a widespread and bilaterally symmetrical lesion within the CNS. In all 
cases, the altered behaviour and neurological deficits slowly progressed which would 
be consistent with a diffuse and progressive intracranial lesion. The presence of the 
ataxia, with variable combinations of: hypermetria, truncal sway, crouched posture, 
tremor at rest, inability to jump up and intention tremor are all consistent with a 
diffuse cerebellar lesion. The altered behaviour in the absence of seizures and with no 
evidence o f a central blindness suggests a diffuse, but relatively mild, forebrain 
lesion.
For a more detailed correlation of the clinical presentation with the observed 
pathological changes see chapter four.
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4.1 Introduction and Aims
The pathology associated with FSE has been reported. These descriptions have been 
limited to a single large series of cases (Pearson et al. 1993), supplemented by a 
number o f individual case reports (Bratberg et al. 1995; Leggett et a l  1990; Zanusso 
et al 1998).
Published pathological reports have predominantly concentrated on the spongiform 
changes evident in the grey matter. These spongiform changes have been described 
as widely dispersed in the CNS and consisting of discrete, round vacuoles in the 
neuropil with an increased prominence in the medial geniculate body, thalamus, 
corpus striatum, cerebellum and deeper cerebral cortex. Vacuolation o f the perikarya 
o f individual neurons has also been reported as part of the spongiform change, 
predominantly in the raphe nucleus, dorsal nucleus o f the vagus nerve, red nucleus 
and vestibular nuclei (Pearson et al. 1993). A widespread glial reaction has been 
reported, as have changes in the white matter associated with axonal degeneration. 
Immunostaining for the presence o f the disease-related isoform of PrP in feline 
spongiform encephalopathy has been reported in only two domestic cats (Bratberg et 
a l 1995; Zanusso et al 1998) and in a puma (Willoughby et a l  1992). In one of the 
cats (Bratberg et a l  1995) there was strong immunolabelling for PrP in the grey 
matter neuropil of the head o f the caudate nucleus, putamen and the cerebral cortex, 
and was similar to previous cases seen by one o f the authors. In the second case 
report (Zanusso et al 1998) the authors claim to have identified a new variant o f FSE 
with the presence o f type-1 PrPSc, rather than the expected BSE-associated type-4 
PrPSc.
In the puma PrP immunolabelling was reported in the medulla and cervical spinal 
cord. A more detailed review o f the literature on the pathology o f FSE and related 
spongiform encephalopathies is included in the introductory chapter (chapter one).
One o f the aims o f this study was to present a detailed description o f the pathology of 
feline spongiform encephalopathy in the cases included in this study. The distribution 
and nature o f changes in the brain and spinal cord were investigated, using classical 
methods and immunocytochemical techniques. This latter aspect includes an 
investigation into both the appearance and pattern of distribution o f the disease-
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related isoform of PrP deposition. An attempt is made to correlate the clinical 
presentation with the observed pathological changes.
4.2 Materials and Methods
4.2.1 Animals
Nine cats with a clinical diagnosis of FSE are included in this study. O f the nine cats, 
pathological material was available from eight of the cases. In the remaining case 
only descriptions of the original pathological report are available. Neural tissues from 
six of the cats were obtained after a retrospective review o f cases presented to the 
pathology department at the University of Glasgow Veterinary School. Three further 
cats were obtained during the course of the study as cases admitted for investigation 
to the neurology service at the University of Glasgow Veterinary School. These cases 
where subsequently confirmed as feline spongiform encephalopathy on post mortem 
examination. Details of the control cases used in the classical histopathological 
methods and immunocytochemical techniques are presented in Table 4 of chapter 2. 
Post mortem examination was performed in all of the cats shortly after euthanasia 
with intravenous injection of pentobarbitone sodium (Euthatal, Rhone Merieux Ltd.). 
In all cases the brain was removed and in those cases where the spinal cord was 
removed the integrity of the dural sheath was maintained where possible. The spinal 
ganglia were dissected out and removed with the spinal cord. The brain was fixed in 
4% BNF (see appendix for fixatives). The spinal cord was suspended in a cylinder in 
4% BNF and weighted to maintain it in straight alignment and avoid any bending 
which would have distorted the structure.
Details of the methodology of, and the precautions taken during the post mortem 
examination are presented in chapter 2.
Details of the tissues that were available and used in this study are presented in Table 
10. As part of the study was performed as a retrospective review, full representative 
tissues were not available from all cases.
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Case no. Available pathological material (individual tissue blocks)
1 XN1241 Medulla oblongata (level of rostral aspect of the dorsal nucleus 
of the vagal nerve)
Medulla oblongata and cerebellum (level o f the descending 
radix of the facial nerve)
Midbrain (level of the commisure of the inferior colliculi) 
Thalamus and cerebral hemispheres (level o f the infundibulum)
2 114446 Medulla oblongata (level o f nucleus o f accessory nerve) 
Medulla oblongata (level o f radix of motor nerve o f the vagus) 
Cerebellum (level of radix o f motor nerve o f the vagus) 
Midbrain (level o f the commisure of the inferior colliculi) 
Cerebral hemispheres (level of septal nuclei)
3 117393 None available
4 118260 Medulla oblongata and cerebellum (level of vagal nerve) 
Thalamus and cerebral hemispheres (level o f the pineal gland)
5 123398 Spinal cord -  lumbar enlargement 
Spinal cord -  thoracic segments 
Spinal cord -  cervical segments
Medulla oblongata (level o f rostral aspect of the dorsal nucleus 
of the vagal nerve)
Medulla oblongata and cerebellum (level of the genu of the 
facial nerve)
Thalamus and cerebral hemispheres (level o f the pineal gland) 
Cerebral hemispheres (level of septal nuclei)
6 126399 Spinal cord -  thoracic segments 
Medulla oblongata and cerebellum (level o f radix of 
hypoglossal nerve)
Midbrain and cerebral hemispheres (level of the commisure of 
the inferior colliculi)
Thalamus and cerebral hemispheres (level o f the premamillary 
nuclei)
Cerebral hemispheres (level of septal nuclei)
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7 129453 Medullas oblongata (level o f nucleus of accessory nerve) 
Medulla oblongata (level o f radix o f hypoglossal nerve) 
Cerebellum (level of radix o f hypoglossal nerve)
Medulla oblongata and cerebellum (level of the descending 
radix of the facial nerve)
Thalamus (level o f the premamillary nuclei)
8 131333 Spinal cord -  sacral segments 
Spinal cord -  sacral segments 
Spinal cord -  lumbar enlargement 
Medulla oblongata and cerebellum (level of the medial 
vestibular nucleus)
Cerebral hemispheres (level of septal nuclei)
Cerebral hemispheres (level of the rostral limit of the caudate 
nucleus)
9 134380 Medulla oblongata and cerebellum (level o f the 
glossopharangeal nerve)
Midbrain and cerebral hemispheres (level of the commisure of 
the inferior colliculi)
Thalamus and cerebral hemispheres (level o f the pineal gland) 
Cerebral hemispheres (level of septal nuclei)
Table 10 Details of the tissues available from each of the pathologically-confirmed 
cases o f feline spongiform encephalopathy used in this study.
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4.2.2 Processing of tissue for paraffin wax sections
The brain was cut into transverse slices. In the FSE cases, prior to processing, the 
brain slices were immersed in a formic acid solution to decrease the potential 
infectivity o f the tissues. In all the FSE cases the brain was processed in a Shandon 
Elliot 24-hour automatic tissue processor (Histokinette) as described in chapter 2. 
The smaller control brain slices (brain stem, cerebellum and occipital cortex) were 
processed in a Shandon Elliot 24-hour automatic processor. The larger control brain 
slices (thalamus and cerebral hemispheres) were processed in a Shandon Elliot seven 
day automatic tissue processor (Histokinette) allowing them to be sectioned whole, as 
described in chapter 2.
In those cases where the spinal cord wras removed, one-cm lengths were removed 
from representative levels. Prior to processing, the spinal cord slices from the 
affected cases were immersed in a formic acid solution to decrease the potential 
infectivity o f the tissues. The spinal cord slices were then processed in a Shandon 
Elliot 24-hour automatic tissue processor (Histokinette).
Paraffin-embedded tissue sections were cut on a Biocut 2035 microtome (Leica) and 
mounted onto Apes-coated microscope slides (for details see chapter 2). Paraffin wax 
sections were routinely stained with H&E (for details see chapter 2).
4.2.3 Morphometry
Details of the methods employed in the histopathological assessment, vacuolar score, 
astrocytic quantification and PrP distribution are described in chapter 2.
4.3 Results
4.3.1 Histopathological assessment of the brain and spinal cord 
In all o f the cases the described changes were very similar, and included the presence 
of grey matter neuropil vacuolation, intra-neuronal vacuolation, a reactive astrocytosis 
and Wallerian-type degeneration o f selective white matter tracts.
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In addition, in three cases evidence o f an inflammatory process was identified by the 
finding o f occasional mononuclear cell perivascular cuffs. In one case only a single 
perivascular cuff in the deep cerebellar white matter was identified, while in the other 
two cases occasional scattered small and medium sized perivascular cuffs were 
present in the brain stem and cerebellum.
4.3.1.1 Grey matter n europil vacuolation
Vacuolation of the grey matter neuropil was present throughout the CNS. However, 
certain regions o f the brain consistently appeared to be more severely affected. In the 
cerebellum the neuropil vacuolation appeared predominantly located in the granule 
cell layer, with occasional neuropil vacuolation present in the molecular layer (Figure 
4). The pattern o f neuropil vacuolation o f the brain stem tended to mirror the 
distribution of the location of the grey matter itself with no particular area spared or 
severely affected. The only exception to this was the marked vacuolation of the 
cochlear nuclei. Throughout the brainstem to the level o f the midbrain scattered 
occasional neuropil vacuolation was present. At the level o f the thalamus marked 
neuropil vacuolation was present in the thalamic nuclei, hypothalamus and medial 
geniculate nucleus, with the surrounding nuclei, including the lateral geniculate 
nucleus, appearing to be less severely affected.
Particularly striking in the cerebral hemispheres was the band of neuropil vacuolation 
affecting the deeper cerebral layers (Figure 5). This was especially evident at the base 
of the cerebral sulci. The degree of neuropil vacuolation o f the cerebral hemispheres 
was relatively mild. This was in stark contrast to the severe neuropil vacuolation of 
the basal nuclei (including the caudate nucleus, globus pallidus and the putamen) and 
the septal nuclei, with the neuropil vacuolation in certain regions o f these nuclei 
becoming confluent. In the caudate nucleus the neuropil vacuolation appeared to 
become more prominent as the junction between the caudate nucleus and the internal 
capsule was approached. In the septal nuclei the neuropil vacuolation increased 
towards the ventral half o f the nucleus.
In contrast to the deeper layers of the cerebral hemispheres and the basal nuclei, the 
hippocampus appeared to only have occasional evidence o f neuropil vacuolation 
(Figure 6). On comparison o f the hippocampus in affected cases to that in control 
cases, the density and thickness o f the layer o f double pyramidal cells appeared
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decreased, indicating the possibility o f neuronal loss in this region. Quantification 
studies were not, however, performed.
4.3.1.2 Neuronal vacuolation
Vacuolation o f individual neurones appeared to follow a strongly conserved pattern, 
with certain nuclei never being affected, some nuclei being affected on an occasional 
basis or at a low level and some nuclei always being moderately or severely affected. 
Occasional small vacuolated neurones could be identified in the band o f grey matter 
neuropil vacuolation in the deep cerebral layers and affecting occasional small 
thalamic neurones. The neuronal vacuolation was most noticeable in the sections 
through the brain stem.
The brain stem nuclei consistently affected at a high level included the dorsal nucleus 
o f the vagal nerve and the dorsal and ventral raphe nuclei. The dorsal nucleus o f the 
vagal nerve, which mainly comprised medium to small neurones, was identified in 
five o f the cases. From 27% to approximately 50% of the neurones in this nucleus 
tended to be vacuolated, with the vacuoles being small to medium sized. The 
majority o f affected neurones had single vacuoles with only the occasional neurone 
having two vacuoles (Figure 7).
The ventral raphe nucleus was identified in five cases, with additionally the dorsal 
raphe nucleus being identified in three of these cases. In all o f the identified raphe 
nuclei approximately half o f the neurones present in the nucleus were vacuolated. 
The vacuoles tended to be medium sized, with the occasional large vacuole. The 
incidence o f multiple vacuoles in these neurones was higher than the dorsal nucleus o f 
the vagal nerve, with some neurones having up to three or four vacuoles.
The hypoglossal nucleus, reticular formation and vestibular nuclei all were affected 
by occasional neuronal vacuolation. In the case of the hypoglossal nucleus this 
feature was identified in three o f the six cases where the section level included the 
hypoglossal nucleus. In these three cases the vacuoles tended to be small and ranged 
from only a single neurone being affected, to three neurones being affected in the 
most severe case. Sections at the level of the reticular formation were available in 
eight cases. In six o f these cases neuronal vacuolation was identified affecting the 
reticular formation. This was characterised by the presence o f very large occasional 
vacuoles (up to four affected neurones in the most severely affected case) affecting
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the nucleus reticularis giganto and in one case each, single neurones with large 
vacuoles in the lateral reticular nucleus and the ventral reticular nucleus.
Vacuolation o f the vestibular nuclei neurones was present in the majority of cases (in 
five of the six cases where the level o f the section allowed evaluation of the vestibular 
nuclei). The neuronal vacuolation of the vestibular nuclei was characterised by the 
presence of medium to large sized vacuoles occurring singularly in affected neurones, 
either in the lateral or the medial vestibular nuclei. This neuronal vacuolation o f the 
vestibular nuclei was present at a low level, with the most severely affected case 
having four vacuolated neurones.
In one case approximately 25% of the neurones in the nucleus periventricularis 
praeopticus contained medium to small sized vacuoles, with the majority of the 
vacuoles occurring singularly. In a second case intra-neuronal vacuolation was 
identified in the nucleus periventricularis hypothalami, again occurring as single small 
to medium sized vacuoles at a moderate frequency.
4.3.1.3 Wallerian-type degeneration o f white matter tracts
Wallerian-type degeneration of the white matter tracts was present throughout the 
CNS, but again certain regions appeared to be consistently affected to a greater 
degree. In the spinal cord the most severe changes were present in the lateral and 
ventral funiculi, particularly in the dorsal aspect o f the ventral funiculus at the 
junction with grey matter. The dorsal funiculus, although still affected, had only 
occasional evidence of degenerating axons.
In the brain the pyramids, cerebral peduncles and internal capsule in the region of the 
corpus striatum were particularly severely affected, with the caudal cerebellar 
peduncles, rubrospinal tracts and in some cases the corpus callosum affected to a 
moderate degree.
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Figure 4 Transverse section through the molecular, Purkinje cell and granule cell 
layers of the cerebellum of an affected cat. The neuropil vacuolation is predominantly 
located in the granule cell layer (arrow) of the cerebellum. (H&E, 35x magnification)
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Figure 5 Transverse section through the base of a cerebral hemisphere sulcus 
(straight arrow) in an affected cat, demonstrating a band of neuropil vacuolation in the 
deeper layers of the cerebral cortex (curved arrow). (H&E, 30x magnification)
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Figure 6 Only occasional neuropil vacuolation (curved arrow) is evident in the 
hippocampus of affected cats, although areas of neuronal loss may be present in the 
layer of double pyramidal cells (straight arrow). (Fl&E, 45x magnification)
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Figure 7 Vacuolation of the perikaryon of individual neurons (curved arrow) in the 
dorsal nucleus of the vagus nerve was a consistently identified feature in affected cats. 
(H&E, 285x magnification)
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4.3.1.4 Astrocytic response
Widespread evidence o f a reactive astrocytosis was evident in all levels o f the brain 
examined, as compared to the neurologically normal control cases. The presence o f a 
reactive astrocytosis could be demonstrated by a subjective increase in the number o f 
astrocytes, by an apparent increase in the astrocytic cytoplasm on H&E sections and 
by an increased prominence o f astrocytic cell processes on GFAP 
immunocytochemistry.
The reactive astrocytosis was particularly evident in the cerebellum, where in addition 
to an increase in the numbers o f Bergmann glia, an increase in both astrocytic cell 
bodies and processes was evident. These changes were particularly evident on 
comparison o f GFAP immunocytochemistry in control cases (Figure 8) to affected 
cases (Figure 9). The increase in astrocytic cell bodies was particularly evident in the 
granule cell layer and white matter tracts o f the cerebellum, while astrocytic processes 
were evident in the molecular o f the affected cases on comparison to with the 
controls.
In addition to the presence of a reactive astrocytosis, an increase in the numbers o f 
microglia was evident on comparison of the affected cases to controls. Exact 
numerical quantification was not performed.
In the spinal cord a reactive astrocytosis was also evident, with the degree appearing 
to correlate with the severity o f the neuropil vacuolation and in areas clusters o f 
astrocytes were identified.
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Figure 8 Transverse section through the cerebellum of a control case demonstrating 
the normal number of astrocytic cell bodies (curved arrow) and processes. The 
subarachnoid space, molecular layer, row of Purkinje cells, granule cell layer and 
white matter tracts can be identified. (GFAP peroxidase-antiperoxidase, 55x 
magnification)
91
Pathological appraisal o f FSE
Figure 9 Transverse section through the cerebellum of an affected cat demonstrating 
an increase in number of both astrocytic cell bodies (straight arrow) and processes 
(curved arrow). (GFAP peroxidase-antiperoxidase, 40x magnification)
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4.3.2 Vacuolar score
The lesion profile in this series of cases revealed a strongly conserved pattern of 
neuropil vacuolation. Due to limited availability o f suitable pathological material in 
certain of the cases in this series, some of the vacuolar scores are based on 
observations in a reduced number of cases. Care must therefore be taken not to over 
interpret the results presented here. Details of the number o f cases included in 
determining the average vacuolar score for each defined region are listed below. 
Consistent with observations that have already been made earlier in this study, certain 
regions appeared to be consistently more, or less severely, affected. The more 
severely affected regions include the thalamic nuclei, the hypothalamus and the septal 
nuclei. Particularly the hippocampus appeared to have only occasional neuropil 
vacuolation. The graphical presentation of the results as a visual profile is shown in 
Figure 10.
CNS regions: Cases included
1. Dorsal medulla 8
2. Cerebellar cortex 8
3. Midline tectum 4
4. Hypothalamus 3
5. Thalamus 6
6. Hippocampus 7
7. Septal nuclei 4
8. Posterior, midline cerebral cortex 7
9. Anterior, midline cerebral cortex 5
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CNS regions: Number:
1. Dorsal medulla 8
2. Cerebellar cortex 8
3. Midline tectum 4
4. Hypothalamus 3
5. Thalamus 6
6. Hippocampus 7
7. Septal nuclei 4
8. Posterior, midline cerebral cortex 7
9. Anterior, midline cerebral cortex 5
Figure 10 Graphical representation of the vacuolar score o f nine defined brain 
regions (lesion profile) in the eight FSE cases in this study where suitable tissue 
sections were available (sample statistics are mean ± standard error).
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4.3.3 PrP Immunocytochemistry of the brain and spinal cord of cats with FSE 
PrP immunocytochemistry revealed a very similar pattern o f PrP deposition between 
all o f the cases. This pattern was characterised not only by the intensity o f the 
deposition, but also by the characteristics o f the deposited material (for example in a 
granular pattern, linear pattern or a more homogenous pattern). The PrP deposition 
tended to occur in the grey matter neuropil, occasionally in a punctate pattern on the 
cell surface, thought to represent synaptic deposition of the PrP, with an absence of 
positive staining in the nuclei of individual cells.
In all control cases no evidence of positive staining for the disease-related PrP 
isoform was evident (details of the cases and tissue levels included are presented in 
Table 4 of chapter 2). These included both the neurologically normal control cases 
and the control cases with a non-prion-related neurological disease.
In the cerebellum of the affected cases there was a marked variation between the 
degree of PrP deposition in the different regions of the cerebellum. The granule cell 
layer appeared to be the region with the most intense PrP deposition, with the 
deposition tending to occur in a granular pattern. The molecular layer had a more 
homogenous and slightly lighter pattern o f PrP deposition, while the Purkinje cell 
layer appeared to have only very mild PrP deposition. This resulted in the Purkinje 
cell layer appearing as a band of decreased PrP deposition between the molecular and 
granule cell layers. In the white matter tracts of the cerebellum there was a paucity of 
PrP deposition (Figure 11). In those cases including a section through the cerebellar 
nuclei, these nuclei appeared to have an slight increase in the degree o f PrP deposition 
when compared to surrounding regions.
In the brain stem of the affected cases, up to the level of the thalamus, the pattern of 
PrP deposition tended to mimic the distribution o f the grey matter neuropil. No 
demonstrable PrP deposition was present in the white matter tracts. The PrP 
deposition tended to occur in a predominantly granular pattern, with certain regions of 
grey matter neuropil and nuclei appearing to have more intense PrP deposition. The 
regions o f grey matter neuropil with a more intense pattern o f PrP deposition (with a 
characteristic granular pattern) included the dorsal nucleus of the vagus, the nucleus 
ambiguus, the nucleus gracilis and the nucleus of the spinal tract of the trigeminal
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nerve. The brain stem nuclei with a more intense pattern o f neuronal PrP deposition 
included the dorsal nucleus o f the vagal nerve, the raphe nuclei, the lateral and ventral 
reticular nuclei, the cuneate nucleus, the olivary nuclei, the medial and lateral 
vestibular nuclei and to a lesser extent the hypoglossal nucleus. Similar to the marked 
neuropil vacuolation o f the cochlear nucleus, this region demonstrated intense 
deposition o f PrP in a granular pattern.
The granular pattern o f PrP deposition was maintained as far rostral as the level o f the 
thalamus, where the thalamic nuclei demonstrated heavy deposition of PrP. The 
deposition o f PrP in individual thalamic neurones appeared particularly marked 
(Figure 12).
In the cerebral hemispheres the pattern o f PrP deposition was particularly striking. In 
particular the basal nuclei (including the caudate nucleus, globus pallidus and 
putamen) and septal nuclei displayed intense PrP deposition. In the caudate nucleus a 
light homogenous pattern o f PrP deposition was superimposed with a coarse granular 
pattern, with an additional linear pattern in regions. The linear pattern probably 
represents deposition of PrP along the processes o f individual neurones. The degree 
of PrP deposition in the caudate nucleus tended to increase towards the junction o f the 
caudate nucleus with the medially situated internal capsule (Figure 13).
The microscopic appearance was very similar in the globus pallidus and putamen to 
that in the caudate nucleus, while in the septal nuclei the superimposed granular 
pattern appeared more delicate and tended to become more intense towards the medial 
aspects o f the septal nuclei.
In the cortices o f the cerebral hemispheres the pattern o f PrP deposition occurred in a 
linear band at the level of the deep cerebral layers, corresponding to the band of 
neuropil vacuolation (Figure 14). A second, less intense and narrower band o f PrP 
deposition was present immediately beneath the surface of the cerebral hemispheres.
Within the spinal cord o f those cases where relevant tissue samples were available the 
pattern of PrP deposition corresponded to the shape o f the spinal cord grey matter. A 
band o f more intense PrP deposition consistently occurred at the level of the second, 
and possibly extending down to the third, spinal cord lamina (Figure 15). Marked
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deposition o f PrP was evident in the large ventral horn neurones and the affected 
neurones tended to display a granular pattern of PrP deposition, thought to represent 
synaptic deposition o f PrP (Figure 16). In the grey matter surrounding the central 
canal, variable PrP deposition was evident with some cases displaying minimal 
deposition in this region, while other cases had an average level o f deposition. No 
PrP deposition was evident in the white matter tracts, although some PrP staining was 
evident in the ventral funiculus along cell process extending from the spinal cord grey 
matter, primarily in a horizontal pattern.
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Figure 11 Characteristic patterns and degrees of PrP immunolabelling are evident in 
the cerebellum of affected cats. The heaviest deposition of PrP occurs in the granule 
cell layer with a granular pattern (straight arrow). The Purkinje cell layer (curved 
arrow) appears as a lightly labelled zone between the granule cell layer and the 
lighter, more homogeneously labelled molecular layer (open arrow). (PrP 
immunocytochemistry plus haematoxylin staining, 30x magnification).
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Figure 12 The pattern of PrP deposition in the thalamus of affected cats tended to 
occur in a granular or punctuate pattern, particularly affecting the neuronal perikaryon 
(straight arrow). Some vacuolation of the perikarya of individual neurons is evident 
(curved arrow) (the absence of immunolabelling of the nuclei should not be confused 
with vacuoles). (PrP immunocytochemistry plus haematoxylin staining, 105x 
magnification).
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Figure 13 Transverse section through the head of the caudate nucleus demonstrating 
the characteristic linear PrP deposits (straight arrow) in an affected cat. The white 
matter tracts are visible at the top right of the picture (curved arrow). The linear PrP 
deposits are similar to those seen in vCJD. (PrP immunocytochemistry plus 
haematoxylin staining, 90x magnification)
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Figure 14 Transverse section through the dorsal and rostral aspect of the cerebral 
hemispheres demonstrating the PrP immunolabelling occurring predominantly in the 
deeper layers of the cerebral cortex (curved arrow). (PrP immunocytochemistry plus 
haematoxylin staining, 15x magnification)
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Figure 15 Transverse section through the lumbar spinal cord of an affected cat 
demonstrating PrP immunolabelling of the grey matter neuropil. The 
immunolabelling of the second and third grey matter laminae is particularly evident 
(curved arrow). (PrP immunocytochemistry plus haematoxylin staining, 22x 
magnification)
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Figure 16 Transverse section through the lumbar spinal cord of an affected cat 
demonstrating the punctuate (synaptic) pattern of PrP immunolabelling of the ventral 
horn cells. (PrP immunocytochemistry plus haematoxylin staining, 240x 
magnification).
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4.4 Discussion
The nature and distribution o f the pathological changes reveals a very similar pattern 
in all the cases in this series. The significant changes are confined to the central 
nervous system (CNS) and include the classical changes to be expected in a 
transmissible spongiform encephalopathy. The changes include vacuolation o f grey 
matter neuropil, vacuolation o f individual neurones, a reactive astrocytosis and 
Wallerian-type degeneration o f selected white matter tracts. O f note is the absence o f 
any demonstrable amyloid plaques, which have been identified in certain other 
transmissible spongiform encephalopathies, including vCJD. The pathological 
changes in this series o f FSE cases correlate well with the limited published details 
available (Pearson et al. 1993; Wyatt et a l  1991).
In three o f the cases mononuclear cell perivascular cuffs are present in the brain stem 
and cerebellum. In one o f these cases only a single perivascular cuff is present, while 
in the remaining two a low number o f scattered perivascular cuffs are present. 
Perivascular cuffs have been identified in reported cases o f FSE (Pearson et al. 1993) 
and their significance is uncertain. They may represent an incidental inflammatory 
process superimposed on the feline spongiform encephalopathy or an inflammatory 
component may exist as part o f the FSE disease process. Inflammatory CNS disease 
due to an underlying infectious agent is a not uncommon diagnosis in the domestic 
cat. As these perivascular cuffs are only present in three cases, and the virus (FIP, 
FeLV and FIV) and Toxoplasma status in these three cases is not known, it is 
probable that these perivascular cuffs do represent an incidental superimposed 
inflammatory disease process. The finding of perivascular cuffs does therefore not 
preclude a diagnosis o f FSE and care must be taken when evaluating feline post 
mortem samples not to overlook subtle spongiform encephalopathy lesions in the 
presence of mononuclear perivascular cuffs.
A set o f criteria have been identified in this series o f cases allowing characterisation 
o f the expected nature and distribution of the pathological features in FSE cases 
arising in conjunction with the BSE epidemic. In the event of a future outbreak o f a 
spongiform encephalopathy in domestic cats the pathological criteria described in this
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study would allow comparison with those o f the new outbreak in order to ascertain
whether the same strain of infectious agent is responsible for both outbreaks.
The identified pathological criteria in this series of cases includes:
1. Widespread grey matter neuropil vacuolation within the CNS, with certain regions 
appearing to be more severely affected. These regions include the cerebral basal 
nuclei (putamen, globus pallidus and caudate nucleus), the septal nuclei, thalamic 
nuclei, medial geniculate nucleus, cerebellar granule cell layer, deep cerebral 
layers and to a lesser extent the spinal cord grey matter. In particular, the cerebral 
basal nuclei and the septal nuclei appear to have the greatest intensity o f 
vacuolation. In contrast, some regions o f the CNS grey matter appeared to have 
only occasional neuropil vacuolation, including the hippocampus and cerebellar 
molecular layer.
2. Vacuolation o f individual neurones in this series of cases appears to have a very 
strongly preserved pattern with a predictable distribution. Nuclei that are 
particularly affected include the dorsal nucleus o f the vagal nerve and the raphe 
nuclei (dorsal and ventral), in which the majority of the neurones are vacuolated. 
In other regions individual neurons appear vacuolated at a much lower frequency, 
although still very predictable in pattern. These nuclei include the vestibular 
nuclei, reticular formation, hypoglossal nucleus, small neurons o f the cerebral 
cortex and occasional spinal cord grey matter neurones.
3. In all o f the cases a widespread reactive astrocytosis in the CNS can be 
demonstrated. This is most striking in the cerebellum where, in addition to an 
increase in the prominence o f astrocytic cytoplasm and numbers o f astrocytic 
nuclei (including Bergmann glia) on H&E sections, a dramatic increase in 
astrocytic processes in the molecular layer on GFAP immunocytochemistry is 
evident.
4. Although Wallerian-type degeneration o f the white matter tracts appears 
widespread, a number o f white matter tracts are selectively affected. These include 
the pyramids, the cerebral peduncles, the caudal cerebellar peduncle, the internal 
capsule in the region of the corpus striatum and to a lesser extent the ventral and 
lateral funiculi o f the spinal cord.
5. Characteristic patterns o f pathological PrP accumulation are present in the CNS 
grey matter on PrP immunocytochemistry. In the cerebellum, the Purkinje cell
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layer appears as a light staining band between the granule cell layer (with the most 
intense PrP deposition in a granular pattern) and the more homogeneously staining 
molecular layer. In the brain stem and mid-brain the PrP deposition occurs in a 
granular pattern, accentuating certain regions, particularly the thalamic nuclei. The 
most striking PrP deposition is present in the basal nuclei and septal nuclei of the 
cerebral hemispheres with a predominantly granular pattern, becoming linear in 
regions, with PrP deposition along cell processes. In the cerebral hemispheres the 
PrP deposition mirrors the band o f vacuolation affecting the deeper cerebral layers.
The pathological abnormalities in these cases allow an explanation o f some of the 
described clinical abnormalities. In all o f the cases the pathological lesion are 
characterised by a widespread and bilaterally symmetrical distribution within the 
CNS. This is consistent with the multifocal and symmetrical localisation of the 
neurological abnormalities.
In particular, the presence o f a symmetrical ataxia, with variable combinations of: 
hypermetria, truncal sway, crouched posture, tremor at rest, inability to jump up and 
an intention tremor are all consistent with the presence of the diffuse and symmetrical 
cerebellar lesion.
Anisocoria characterised by pupillary dilation contralateral to an asymmetrical 
cerebellar lesion, with intact pupillary light reflexes, has been reported as an 
occasional finding (DeLahunta 1983). The diffuse cerebellar lesion in this series of 
cases may therefore explain the presence of bilateral pupillary dilation with intact 
pupillary light reflexes. The precise mechanism is unclear (if the hypothesis is 
correct) and may relate to a loss o f cerebellar modulation o f the inhibitory 
prosencephalic pathways acting on the oculomotor general visceral efferent neurones.
The diffuse vacuolation affecting the deeper cerebral layers may allow explanation of 
the altered behaviour, with the lesion being insufficiently severe to result in seizures 
or decreased vision. Either the diffuse cerebral lesion or the selective vacuolation and 
PrP deposition o f the thalamic nuclei may explain the conscious proprioceptive 
deficits found in a number o f the cases.
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The marked neuropil vacuolation of the basal and septal nuclei of the cerebral 
hemispheres is particularly evident in this series o f cases. The functions of these 
nuclei are not fully understood, but experimental ablation o f the caudate nucleus in 
the cat has been performed. In the experimental cases, removal of the caudate nuclei 
resulted in no obvious motor disturbance but behavioural abnormalities were noted, 
including the presence o f hyperaesthesia (Villablanca et a l  1976). In the series of 
cases in this study the hyperaesthesia and some o f the behavioural abnormalities can 
therefore be explained by the severe lesions in the caudate nucleus.
The presence o f hypersalivation in a number o f cases in this series is difficult to 
explain. One possibility may be facilitation o f parasympathetic efferents from either 
the facial or glossopharyngeal nuclei due to a loss of higher centre inhibition o f these 
nuclei. No obvious clinical signs can be ascribed to the consistent and severe 
neuronal vacuolation that is present in the dorsal nucleus o f the vagus and the raphe 
nuclei. No inability to swallow food was identified in this series of cases and it is 
therefore unlikely that the clinical feature o f “hypersalivation” is actually a 
consequence o f dysphagia.
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It is recognised that different strains of infective agent must be present to explain the 
patterns of disease among the described transmissible spongiform encephalopathies. 
A single strain of infective agent results in a strongly conserved pattern of disease in a 
specified host-type. Differentiation between the strains can be achieved by 
demonstrating the different disease characteristics they cause in both naturally 
occurring cases and in experimentally infected animals. In particular, the clinical 
presentation, incubation period and characteristic neuropathology (including the 
lesion profile of spongiform changes and distribution o f PrPSc within the CNS) allow 
differentiation between the strain types.
Consistent with this strain hypothesis, all except one (Zanusso et al. 1998) of the 
reported cases of Feline Spongiform Encephalopathy (FSE) have a similar clinical 
presentation and neuropathology, suggesting that they have arisen from a common 
source. Based on the reported different clinical presentation and neuropathology, the 
case from Italy (Zanusso et al. 1998) is hypothesised to have arisen from a different 
strain of the infective agent, more consistent with that resulting in sporadic CJD.
The first case o f FSE was reported in 1990 by Wyatt et al., just over three years after 
Bovine Spongiform Encephalopathy (BSE) was first identified. Strong circumstantial 
evidence exists to suggest a link between the strain o f infective agent responsible for 
FSE and BSE. This link is likely to be through a common origin, or from cats being 
exposed to either BSE infected tissues or a product of BSE infected tissues. Certainly 
the temporal and geographic occurrence of FSE suggests an origin from BSE rather 
than scrapie (Bradley 1997). The weight of evidence suggests that the source of 
infection in cats is likely to be related to the feeding o f BSE-contaminated feed.
Supportive of the strain hypothesis, a number o f studies have demonstrated a link 
between the agent causing BSE, new variant CJD, FSE and the TSE of exotic 
ungulates in the UK. This agent appears to be distinct from that causing iatrogenic 
and sporadic CJD (Collinge et al. 1996).
Transmission of FSE to mice (Fraser et al. 1994) has demonstrated similar incubation 
periods, lesion profile and percentage o f affected mice as that o f BSE but distinct 
from that o f scrapie. The authors concluded that FSE and BSE are likely to have 
arisen from a similar source.
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Western blots of PrPSc after proteolytic cleavage, in the sporadic and iatrogenic forms 
of CJD, allow differentiation between the type-1, type-2 and type-3 forms by 
evaluation of differing band sizes. Type-4 CJD, or new variant CJD, while having 
similar band sizes to type-3 CJD, can be clearly distinguished from the other three 
forms of CJD by a characteristic pattern of band intensities (Collinge et a l 1996; 
Aguzzi and Weissmann 1996). Similar western blot analysis o f BSE, naturally 
occurring FSE and experimental BSE in a macaque revealed an almost identical 
pattern of band intensities, which was distinct from that o f type-1, type-2 and type-3 
CJD. From this it was concluded that new variant CJD, BSE and FSE are all due to 
infection from a common source, with the same strain o f PrPSc.
A study by Bruce et a l (1997) demonstrated striking similarities in the lesion profile 
for RIII mice after transmission of new variant CJD from three cases, BSE from four 
cattle, FSE from two cats and a spongiform encephalopathy from a nyala and a kudu. 
This lesion profile was distinct from that generated by transmission into panels of 
these mice o f scrapie from six sheep and sporadic CJD from two cases. As a further 
part o f the same study, which is still on-going at the time o f my study, a strong 
correlation has been demonstrated between the incubation periods in four strains of 
mice after transmission of new variant CJD from three sources, BSE from eight 
sources and FSE from two sources. This correlation is again distinct from that 
obtained by transmission of scrapie from six sources into the same panel of mice. The 
authors concluded that it is likely that the same agent strain is responsible for new 
variant CJD, BSE, FSE and the TSE in captive exotic ungulates in the UK.
Prior to my study only limited published clinical and pathological descriptions of FSE 
were available. Certain criteria have been identified in my study allowing the 
characterisation of the expected clinical and pathological profile of FSE cases 
occurring in conjunction with the BSE outbreak. These criteria are discussed in 
greater detail in the relevant chapters and allow the characterisation o f the BSE- 
related strain of infective agent in cats. Should a future outbreak o f a spongiform 
encephalopathy occur in domestic cats the identified clinical and pathological profile 
could then be compared to the criteria identified in this study in order to determine 
whether a different strain of infective agent was responsible for the new outbreak.
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The clinical and pathological features in the different cats included in my study 
appear constant, suggesting that the same strain of infectious agent was responsible 
for all o f the cases. Additionally the clinical and pathological features in this series of 
cases bear a strong resemblance to that described for vCJD, with in particular the 
initial altered behaviour followed by ataxia, and the marked pathological 
abnormalities with linear PrP deposits in the basal nuclei, being similar. The absence 
o f demonstrable amyloid plaques in the FSE cases is a notable difference.
The FSE outbreak has resulted in a better understanding of TSE’s with the 
opportunity to study freshly collected pathological material derived form a natural 
source. The cat is a useful model to allow predictions on the future disease 
prevalence in the human population. In both the cat and man the disease appears to 
have been derived from a common source, both populations are likely to have been 
exposed through ingestion o f the infective agent and both man and the cat are 
monogastrids. The occurrence of a TSE in lemurs fed on bovine derived protein in a 
French zoo does, however, suggest that lemurs may be a better animal model in which 
to study TSE’s as they have a closer genetic relationship to man.
Further research into FSE would allow further understanding o f the disease process. 
To support evidence to suggest that PrP infectivity can be identified in the lymphoid 
tissues, analysis on samples taken from some o f the cases in my study are ongoing. 
This includes PrP immunostaining on lymphoid tissue and Western blots on fresh 
frozen lymphoid and brain tissue.
The absence o f an identified spongiform encephalopathy in the domestic dog suggests 
there may be a genetic difference in susceptibility between the cat and dog. Both the 
domestic dog and cat have been exposed to similar environmental and dietary risk 
factors. Sequencing of both the canine and feline PrP gene to allow comparison, and 
particularly codon 129, would be of interest. Furthermore, this would allow the 
importance of codon 129 in determining the genetic susceptibility to the BSE-related 
strain of infective agent in the domestic cat to be determined. This may allow a more 
accurate prediction of susceptibility of the human population to the BSE-related 
infective agent, with regard to PRNP codon 129 genotype.
I l l
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6.1 Tissue fixation and processing
6.1.1 Buffered neutral formaldehyde, 4% (BNF)
To prepare 1 litre of fixative:
40% formaldehyde* 100ml
tap water 900ml
sodium dihydrogen orthophosphate 4g
dipotassium hydrogen orthophosphate 8g
*40g paraformaldehyde in 100ml water, heat to between 60°C and 70°C, addlM  
sodium hydroxide drop by drop until the precipitate has cleared. Cool to 4°C.
6.1.2 Paraffin wax processing
Solutions used in the Shandon Elliot 24-hour automatic tissue processor (Histokinette) 
to prepare BNF perfused blocks from the spinal cord, brain and lymphoid tissues for 
paraffin embedding:
1) 70% methylated spirits / 5% phenol 2 hr room temperature
2) 90% methylated spirits / 5% phenol 2 hr room temperature
3) methylated spirits 2 hr room temperature
4) ethanol / 5% phenol 2 hr room temperature
5) ethanol / 5% phenol 1 hr room temperature
6) ethanol / 5% phenol 1 hr room temperature
7) 1% celloidin in methyl benzoate1 4 hr room temperature
8) xylene 1 hr room temperature
9) xylene 1 hr room temperature
10) xylene 1 hr room temperature
11) paraffin wax 4-6 hr 60°C
12) paraffin wax 7 hr 60°C
Necloloidine (Merck) solution for microscopy was considered to be 100% celloidin 
(lm l added per 100ml methyl benzoate)
Solutions used in the Shandon Elliot 7-day automatic tissue processor (Histokinette) 
to prepare BNF perfused blocks from the brain, primarily larger blocks from control 
cases, for paraffin embedding:
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1) 70% methylated spirits/5% phenol 6 hr room temperature
2) methylated spirits lOhr room temperature
3) absolute alcohol/5% phenol 6 hr room temperature
4) absolute alcohol/5% phenol 6 hr room temperature
5) absolute alcohol/amyl acetate 4 hr room temperature
6) amyl acetate I lOhr room temperature
7) amyl acetate II lOhr room temperature
8) 1% celloidin in methyl benzoate1 20 hr room temperature
9) 1% celloidin in methyl benzoate1 20 hr room temperature
10) xylene 4 hr room temperature
11) paraffin wax 14 hr 60°C
12) paraffin wax 10-20 hr 60°C
Necloloidine (Merck) solution for microscopy was considered to be 100% celloidin 
(lml  added per 100ml methyl benzoate)
6.2 Staining protocols and stains
6.2.1 Haematoxylin and eosin
Sections were passed through the following solutions:
1) histoclear 2 min
2) absolute alcohol 2 min
3) methylated spirit 2 min
4) water 2 min
5) Lugol’s iodide* 1 min
6) water 1 min
7) 5% sodium thiosulphate 1 min
8) water 2 min
9) Mayer’s haematoxylin* 10 min
10) 1% acid alcohol* 3 dips
11) water 2 min
12) Scot’s tap water substitute* 1 min
13) water 2 min
14) methylated spirit 10 sec
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15) saturated aqueous eosin 2 min
16) methylated spirit 10 sec
17) absolute alcohol 2 min
18) histoclear 2 min
19) xylene 1 min
* for details see Staining solutions
6.2.2 Haematoxylin
Immunocytochemistry sections were counter stained as appropriate:
i) running water 2 min
2) Mayer’s haematoxylin* 50 sec
3) water wash off excess haematoxylin
4) Scot’s tap water substitute* 30 sec
* for details see Staining solutions
6.2.3 Staining solutions 
6.2.3.1 Lugol’s Iodine
lg Iodine
2g Potassium iodide
Made up to 100ml with distilled water
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6.2.3.2 Mayer’s haematoxylin
lg haematoxylin
log potassium alum
0.2g sodium iodate
in 1 litre of distilled water, bring to boiling point and allow to cool overnight, then
add:
lg citric acid
50g chloral hydrate
6.2.3.3 1% Acid Alcohol 
1% HC1 in methylated spirit
6.2.3.4 Scot’s tap water substitute
3.5g sodium bicarbonate
20g magnesium sulphate
in 1 litre of distilled water
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Abbreviations
A Adenine or Adenosine
Ala Alanine
ALT Alanine transferase
APES 3 -aminopropyltriethoxy-silane
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AST Aspartate transferase
BNF Buffered neutral formaldehyde
bp Base pair
BSE Bovine spongiform encephalopathy
°C Degrees centigrade
c Cytosine
C2 Second cervical spinal cord segment
C3 Third cervical spinal cord segment
C6 Sixth cervical spinal cord segment
C7 Seventh cervical spinal cord segment
CJD Creutzfeldt-Jakob disease
cm Centimetre
CNS Central nervous system
CSF Cerebrospinal fluid
CT Computed tomography
DNA Deoxyribonucleic acid
DRG Dorsal root ganglion
EEG Electroencephalogram
EU European Union
F Female
FeLV Feline leukaemia virus
FFI Fatal familial insomnia
FIP Feline infection peritonitis
FIV Feline immunodeficiency virus
FN Female neutered
FSE Feline spongiform encephalopathy
g Gram
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G Guanine or Guanosine
GFAP Glial fibrillary acidic protein
GIT Gastrointestinal tract
Gin Glutamine
Glu Glutamic Acid
Gly Glycine
GPI Glycosylphosphatidylinositol anchor
GSS Gerstmann-Straussler-Scheinker disease
GSSD Gerstmann-Straussler-Scheinker disease
GUVS Glasgow University Veterinary School
H&E Haematoxylin and eosin
HC1 Hydrochloric acid
His Histidine
hr Hour
He Isoleucine
IU International unit
kb Kilobase
kg Kilogram
L Litre
LA Long-acting
Leu Leucine
Lys Lysine
M Molar
Met Methionine
mg Milligram
min Minute
ml Millilitre
MN Male neutered
MRI Magnetic resonance imaging
mRNA Messenger ribonucleic acid
NGS Normal goat serum
p53 Protein which has been associated with many tumours
PAP Peroxidase anti-peroxidase
PBS Phosphate buffered saline
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Phe Phenylalanine
PNS Peripheral nervous system
PRNP Human prion protein gene
Pro Proline
PrP Prion protein
PrP Normal cellular isoform of prion protein
PrP-null Genetically modified strain of animal which fail to produce PrP
PrPSc Protease-resistant disease-related isoform of prion protein
RBC Red blood cell
sec Second
Ser Serine
sip Scrapie incubation period
S-S Disulphide bond
T Thymine or Thymidine
T2 Second thoracic spinal cord segment
T3 Third thoracic spinal cord segment
T4 Fourth thoracic spinal cord segment
TME Transmissible mink encephalopathy
TSE Transmissible spongiform encephalopathy
TSE’s Transmissible spongiform encephalopathies
Tyr Tyrosine
pm Micrometer
UK United Kingdom
USA United States of America
Val Valine
vCJD New variant CJD
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